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The cohesin complex is essential for cell survival, owing to its well-established roles in cell 
division, DNA repair and gene expression. Malignancy and developmental disorders termed 
the cohesinopathies can result when mutations are present in cohesin subunits, or in 
proteins that interact within cohesin. 
 
 In this thesis, I describe experiments using the rad21nz171 zebrafish mutant line, which 
carries a null allele for cohesin subunit Rad21, to address cohesin’s role in driving 
malignancy and normal development. The thesis is in two sections.  
 
The first section examines the functionality of a germline RAD21 variant that may be 
responsible for the development of myelodysplastic syndrome in a cohort of patients. 
RAD21 functionality can be  determined through the use of a zebrafish runx1 in situ 
hybridisation bioassay, and this research found that the familial variant produces a 
functional cohesin subunit. A novel RAD21 variant was designed and assayed alongside the 
familial variant, and found to be non-functional.  
 
The second section focuses on the role of cohesin in regulating normal embryogenesis. 
High-throughput RNA-sequencing was performed on the elongating tailbuds of rad21nz171 
zebrafish embryos compared to wildtype siblings, to elucidate which genes and biological 
pathways cohesin is fundamental in regulating during zebrafish embryogenesis. The tailbud 
was chosen for examination as the posterior of the zebrafish develops from a bipotent 
stem cell population in this structure, and a lack of cohesin-regulated gene expression is 
predicted to affect cell fate decisions of the stem cells. An abundance of metadata was 
generated from the RNA-sequencing analyses, providing numerous avenues for further 
exploration. The spatial expression of four genes identified in these analyses were 





We discovered that in the absence of cohesin-regulation, the fate of bipotent stem cells in 
the developing zebrafish tailbud skews towards neural ectoderm over mesodermal 
progenitors, and theorise that this shift is due to dysregulation of wnt3a, a key regulator of 
zebrafish axial elongation. A role for cohesin in regulating ribosome biogenesis, and thus 
protein translation, was identified in these analyses. The involvement of cohesin in 
assisting in protein translation implicates cohesin as regulating gene expression not only at 
the gene, but protein level also – a role which has not been well explored in the literature 
to date.  
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1 INTRODUCTION  
The cohesin complex could be referred to as the “circle of life” as it underlies multiple key 
processes within a living cell and its functionality is imperative for survival. The name 
cohesin was coined due to the complex’s role in the holding together of sister chromatids 
from S phase until G2 phase of the cell cycle, but it is now well established that, in addition 
to its cell cycle role, cohesin also works to organise 3-dimensional chromosome 
conformation and interactions with regulatory elements. Cohesin’s influence in regulating 
gene expression opens doors to exploring this role not only in normal development, but in 
abnormal development and malignancies. 
1.1 The cohesin complex 
 
Figure 1-1 - The cohesin complex. Left-Schematic of the cohesin complex, with subunits annotated for 
orientation. Middle – Schematic of a cohesin complex holding two chromosomes in close proximity via the 
“handcuff” model. Right – Schematic of a cohesin complex holding two regions of a single chromosome 
together via the “loop extrusion” model.  
1.2 Cohesin structure and roles 
The cohesin complex is a tripartite ring, containing two structural maintenance of 
chromosomes (SMC) subunits SMC1 and SMC3, and an α-kleisin subunit (Chavda et al., 
2017; T. Gligoris & Löwe, 2016; Nasmyth & Haering, 2009). SMC1 and SMC3 are large 
proteins that join together at one end to form a hinge domain, leaving their ATPase heads 
to interact with the α-kleisin subunit (T. G. Gligoris, 2018; Haering et al., 2004; Nasmyth & 
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Haering, 2005). The α-kleisin interacts with stromal antigen subunits (STAG/SA/Scc3) (Viny 
et al., 2019; Ward et al., 2016)(Figure 1-1). The α-kleisin RAD21, also termed Scc1 or Mcd1 
in yeast, is essential for cohesin’s normal function, as there are no homologous proteins 
produced which can perform its role (Birkenbihl & Subramani, 1992; Sonoda et al., 2001; 
Tomonaga et al., 2000). The human RAD21 protein is 631 amino acids long and is encoded 
on chromosome 8 (Dorval et al., 2020). RAD21 not only links together SMC structures but is 
the only subunit of the cohesin complex which is noted to directly bind accessory proteins, 
recruiting them to carry out their function at cohesin-binding sites (Dorsett & 
Merkenschlager, 2013). The stromal antigen proteins, termed STAG1, STAG2 and STAG3 in 
humans, all have similar sequences, yet favour different roles within a cell. STAG3 is 
associated with meiotic cohesin, while STAG1 and STAG2 are ubiquitous (Casa et al., 2019; 
Prieto et al., 2001). Despite STAG3 being associated with meiosis 1, all STAG orthologues 
have the ability to bind to RAD21 in all cell types, so even a homozygous mutation for one 
of these genes is not lethal (Viny et al., 2019). The Human STAG2 protein is encoded on the 
X chromosome, therefore in males only a single hit to this gene is sufficient to knock out 
STAG2 function (Mullegama et al., 2019). Many cancers have a high STAG2 mutation rate, 
as though STAG1 can compensate for STAG2 function, the reduction in overall STAG 
protein may still affect normal cell division and gene expression (Romero-Pérez et al., 2019; 
Viny et al., 2019). Human STAG1 is encoded on chromosome 3 and STAG3 on chromosome 
7 (Romero-Pérez et al., 2019). 
 
Cohesin’s loading onto chromosomes, maintenance and turnover are controlled by several 
other proteins (Nasmyth & Haering, 2009; Xiong & Gerton, 2010). It is proposed that 
cohesin is loaded and unloaded from chromosomes by a “dual gate” mechanism, in which 
cohesin snaps onto DNA via opening of the SMC hinge domains, and exits DNA via cleavage 
of the ring at the opposite end, at the a-kleisin interface (Nasmyth, 2011). There are a 
number of different models for how cohesin interacts with DNA, notably, the handcuff 
model and the sliding filament, or loop extrusion model (Figure 1-1). Locking chromosomes 
within a cohesin ring in a handcuff-like manoeuvre is the basis of the handcuff model (Eng 
et al., 2015; N. Zhang et al., 2008). The sliding filament, or loop extrusion model proposes 
instead that cohesin is loaded onto the DNA and slides along it, looping off regions of DNA 
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(Barrington et al., 2017; Davidson et al., 2019; Kim et al., 2019). Once loaded onto 
chromosomes, cohesin binds to DNA with variable degrees of permanency (Rhodes et al., 
2017; H. Zhang et al., 2019), and has the ability to move along chromosome arms 
(Lengronne et al., 2004; Ocampo-Hafalla et al., 2016). During mitosis, cohesin is bound for 
long enough to fulfil its function in sister chromatid cohesion, due to acetylation by cohesin 
acetyl transferase (CoAT) proteins generating a stably bound form of cohesin along sister 
chromatids (Hou & Zou, 2005; Ivanov et al., 2018; Sun et al., 2019).  Phosphorylation of 
cohesin assists in unloading cohesin as mitosis progresses, with centromeric cohesin the 
last of the stably bound cohesin to be removed (Hauf et al., 2005; Stormo & Fox, 2018). 
Stably-bound cohesin also works to hold homologous chromosomes together when a 
double-stranded break occurs, allowing repair machinery to use the intact chromosome as 
a template to repair the damage (Dorsett & Ström, 2012; Watrin & Peters, 2006). Cohesin 
complexes are enriched at damaged DNA sites (Hagstrom & Meyer, 2003), which supports 
the notion that the complex assists in holding chromosomes together while repair is 
undertaken. Cohesin’s roles are not limited to assisting in cell proliferation and repair. In 
fact, cohesin is at the forefront of many modern studies because of its role in influencing 
gene expression (Dorsett & Ström, 2012; Richterova et al., 2017; Watrin et al., 2016). It is 
now well established that the cohesin complex can recruit activating or repressive 
regulators to distinct DNA sites to have their effect (Dorsett, 2019; Rahman et al., 2015). 
Newer studies have evidence for cohesin working alongside CTCF, a DNA binding protein 
that acts as a chromatin insulator, to regulate gene expression (Merkenschlager & Nora, 
2016; Parelho et al., 2008; Pugacheva et al., 2020). 
1.3 Topological organisation of the genome 
Cohesin and CTCF work together to organise the 3-dimensional (3D) genome (Chavda et al., 
2017; Chen et al., 2019; Kentepozidou et al., 2020). The CTCF protein contains 11 zinc 
finger proteins, which bind to side chains of exposed nucleotides in the major groove of 
consensus sequence DNA (Hansen et al., 2019). CTCF is the direct link between chromatin 
and cohesin at consensus sites, as the cohesin α-kleisin subunit directly binds to CTCF, 
which in turn is bound to consensus DNA (Pugacheva et al., 2020). CTCF knockdown results 
in a loss of cohesin recruitment to CTCF consensus sites, while knockdown of cohesin 
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resulted in a loss of CTCF’s insulator function, with the resulting idea that both CTCF and 
cohesin are required to mediate insulated domains within local chromosome areas (Ali et 
al., 2016; Nora et al., 2017; Parelho et al., 2008). Cell-type-specific cohesin and CTCF 
binding supports the idea that these two complexes organise cell-type-specific gene 
expression patterns, depending on regulatory elements (activators or silencers) held within 
proximity of coding genes in cohesin and CTCF organised chromatin (Barrington et al., 
2019; Mir et al., 2019). 
 
 
Figure 1-2- Schematic of nuclear 3D organisation. Left - A nucleus, with distinct chromosome territories in 
different colours. Red square highlights a portion of a hypothetical active compartment. Middle - Close up of a 
region of the active compartment, showing 2 distinct TADs, each insulated by CTCF (blue) and cohesin (pink). 
Right - Close up of an insulated neighbourhood within one of the TADs, depicting CTCF and cohesin insulating 
a neighbourhood, while cohesin also works to organise local chromosome interaction through bringing a gene 
and enhancer together in a loop.  
Individual chromosomes segregate into “chromosome territories” throughout the nucleus, 
and A (active) and B (inactive) compartments bring together regions of mostly active and 
inactive transcription (Cremer et al., 2015; Fritz et al., 2016, 2019). Within A and B 
compartments, the genome is insulated into distinct chromatin domains, based upon 
whether single genes or groups of genes are actively or inactively transcribed. The largest 
of these regions are termed topologically associating domains (or TADs), in which cohesin 
and CTCF loop off a genomic region, resulting in a high frequency of interactions within 
that part of the genome (Barrington et al., 2019; Kentepozidou et al., 2020) (Figure 1-2-B). 
TADs are a large, tangible compartmentalisation of the chromosomes, in which interactions 
can occur, and just as importantly, interactions cannot occur between (Dixon et al., 2016; 
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Mir et al., 2019). These large TADs contain sub-TADs – which are simply smaller 
compartments of chromatin also insulated by cohesin and CTCF. Within sub-TADs are 
insulated neighbourhoods, smaller-again compartments insulted by cohesin and CTCF, 
where cohesin can entrap chromosomes to bring together regulators and genes at a local 
level (Figure 1-2-C) (Dowen et al., 2014; Hnisz et al., 2016; Sun et al., 2019). While TADs are 
conserved across related species, between different cell lineages the organisation of sub-
TADs and insulated neighbourhoods differs, depending on the gene expression 
requirements of the cell type (Ali et al., 2016; Dowen et al., 2014). TADs across the genome 
are shown to be disrupted in mitosis, yet re-established straight after, consistent with the 
fact that cohesin localises to function in sister chromatid cohesion, then returns post-
division to organise gene expression patterns (Hansen et al., 2017; H. Zhang et al., 2019).  
1.4 Pathologies associated with cohesin dysregulation 
As cohesin’s many roles within a cell provide chromosomal integrity and the expression of 
essential genes, when cohesin levels are reduced, or lost, pathologies can occur.  A total 
cohesin knockout is lethal, while a partial knockdown can be survivable, with a spectrum of 
phenotypes (J. Horsfield et al., 2012; Piché et al., 2019).  The best known of these 
pathologies is Cornelia de Lange syndrome (CdLS), a broad-spectrum syndrome with 
multiple physical and cognitive abnormalities (Bergeron et al., 2019; Boyle et al., 2017; 
Mulder et al., 2017). CdLS patients are small in size and have a distinctive facial 
appearance, including arched eyebrows, long eyelashes, an upturned nose, thin upper lip, 
and an undersized jaw (Basel-Vanagaite et al., 2016; Yuan et al., 2019). Observed anomalies 
range from mild to severe, with the most severe having truncated limbs (Mehta et al., 
2016). All patients within the CdLS spectrum have variable degrees of cognitive delay 
(Mikołajewska, 2019; Mulder et al., 2017). Nearly 70% of CdLS cases are caused by 
mutations in the NIPBL gene, one of the essential cohesin-loading proteins (Kaur et al., 
2016; Masciadri et al., 2018). Mutations in SMC1 and SMC3 also give rise to CdLS 
phenotypes, and account for around 5% of cases. SMC-associated CdLS phenotypes are 
milder than those associated with NIPBL, though mental retardation is still present 
(Baquero-Montoya et al., 2014; Huisman et al., 2017). RAD21 mutations are causative of a 
cohesinopathy syndrome which partially phenocopies CdLS, though the observed 
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symptoms are even milder than patients with SMC mutations, presenting with mild 
cognitive and physical abnormalities (Deardorff et al., 2012; Dorval et al., 2020). Another 
rare human disorder, termed Roberts syndrome (RBS) is caused by mutations in ESCO2, a 
protein that acetylates cohesin, allowing adherence of sister chromosomes in mitosis 
(Banerji et al., 2017). The disorder is therefore due to premature separate of the 
chromosomes during mitosis (Tuuli & Odibo, 2018). Due to the numerous cohesin and 
cohesin factor mutations underlying these pathologies, the term “cohesinopathy” is used 
to describe these disorders. Most cases of cohesinopathy are heterozygous for mutations 
related to cohesin functionality, and the resulting loss of functional cohesin is predicted to 
provide enough cohesin to drive mitotic cell division yet be insufficient to drive expression 
of all of the essential developmental genes in a developing foetus, as there are so many, 
resulting in the abnormal phenotypes (Cucco & Musio, 2016; Tuuli & Odibo, 2018). Though 
it is theorised that the cohesinopathies all result from some degree of gene expression 
dysregulation, there are distinct differences in phenotypes observed when different 
components of the cohesin cycle are affected, indicating that the cohesin complex subunits 
have an affinity for regulating particular genes (Casa et al., 2019).  
 
A loss of cohesin has also been attributed to myeloid malignancies, a group of 
haematopoietic diseases that are detrimental to survival. Myelodysplastic syndrome (MDS) 
and acute myeloid leukaemia (AML) are the two most common myeloid malignancies 
(Fisher et al., 2017; Fröhling et al., 2005; Shih et al., 2012). In MDS, hematopoietic stem cell 
function is compromised, resulting in dysplastic bone marrow (Gangat et al., 2016; 
Mhawech & Saleem, 2001), while in AML, myeloid progenitors do not differentiate into 
functional blood cells (De Kouchkovsky & Abdul-Hay, 2016; Saultz & Garzon, 2016). 
Compared to cancers derived from other tissues, myeloid cancers only require 5-15 
mutations to drive malignancy (Farrar et al., 2016; Yoshida et al., 2013). While the 
mutational landscape of these malignancies is well characterised (Kandoth et al., 2013), the 
critical combination of somatic mutations leading to malignant progression is not yet 
established. Mutations in cohesin subunits are prominent in myeloid malignancies, 
occurring in 12.1% of acute myeloid leukaemias and 8.0% of myelodysplastic syndromes 
(Kon et al., 2013). Somatic cohesin mutations are implicated as a critical step in these 
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disease’s development, as they tend to occur early within disease progression (Fisher et al., 
2017; Hill et al., 2016; Losada, 2014). Patients with myeloid malignancy, yet a stable 
karyotype, are predicted to be a result of cohesin ineffectively controlling gene expression 
(Losada, 2014).  Like with all malignancies, no myeloid dysplasia has been observed with a 
single mutation, and cohesin-subunit mutations are just one of a number of “hits” to the 
genome which drive malignancy for these patients.  
 
1.5 Restoring runx1 expression to test Rad21 functionality  
 
Figure 1-3 - Restoring runx1 expression to test rad21 functionality. 13-hpf embryos imaged after runx1 in situ 
hybridisation. Haematopoietic mesoderm (HM) and Rohon Beard neurons (RB) labelled.  Left - Embryo with 
genotypically-functional Rad21 and resulting runx1 expression in the RB and HM. Right - Embryo genotypically 
mutant for rad21. Exhibits loss of HM runx1 expression, while maintaining runx1 expression in the RB. 
The Horsfield lab has previously shown that rad21-homozygous mutant embryos exhibit 
differences in tailbud runx1 expression relative to rad21-wildtype and rad21-heterozygote 
embryos at 13 hours post fertilisation (Figure 1-3). Embryos that produce functional Rad21 
exhibit runx1 expression in the haematopoietic mesoderm (HM), while Rad21-homozygous 
mutant embryos do not. (Horsfield et al., 2007). Microinjection of rad21 mRNA into rad21-
homozygous mutant embryos rescues HM runx1 expression, producing embryos that 
present with wildtype-like runx1 expression patterns at 13 hours post fertilisation 
(Horsfield et al., 2007). The functionality of human RAD21 mutations underlying 
cohesinopathies have been assayed through determining if analogous variant forms of 
rad21-mRNA could rescue runx1 expression in the haematopoietic mesoderm of rad21-
homozygous mutant embryos (Deardorff et al., 2012).   
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1.6 The canonical WNT pathway  
  
Figure 1-4 - The canonical Wnt signalling pathway. Image adapted from Wang et al 2004. Left - When Wnt 
receptor  complexes are not bound by Wnt molecules, kinases CK1 and GSK3α/β phosphorylate β-catenin. 
Phosphorylated β-catenin is recognized by the ubiquitin ligase complex, which ubiquitinates it, targeting it for 
rapid destruction.  In the nucleus, Groucho is bound to TCF, inhibiting the transcription of Wnt target genes. 
Right - Once bound by Wnt, receptor complexes activate the canonical signalling pathway. When Wnt binds, 
the destruction complex becomes disrupted. Axin and the destruction complex translocate to the receptor, and 
rather than target β -catenin for degradation, a series of phosphorylation events inhibit the GSK3α/β from 
doing so. Thus, β -catenin accumulates in the cytoplasm and translocates to the nucleus, where it can displace 
Groucho, and recruit other regulators to drive the expression of Wnt target genes 
The canonical Wnt pathway and Wnt target genes drive virtually every aspect of 
development, as well as maintaining adult tissues – making this field a hot spot for 
understanding both normal development and pathogenicity (Butler & Wallingford, 2017). 
The canonical pathway for Wnt signal transduction is outlined in Figure 1-4. When the 
pathway is activated by Wnt, β-catenin moves to the nucleus, where it displaces groucho 
from TCF sites, allowing the transcription of Wnt target genes (Wang & Wynshaw-Boris, 
2004). These Wnt genes are responsible for axis patterning as well as cell specification, 
proliferation and migration (Darras et al., 2018; Xing et al., 2018). The canonical Wnt 
pathway is imperative in organising germ layers in the developing zebrafish tailbud. As the 
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posterior tailbud extends, bipotent stem cells make ectodermal or mesodermal decisions 
based upon their exposure to Wnt signalling (Martin & Kimelman, 2012). 
1.7 Zebrafish as a model organism 
Zebrafish are a popular animal model, for many reasons. Zebrafish are a genetically 
tractable vertebrate model on which cellular and molecular manipulation are possible. 
Zebrafish are small, easy to maintain, and can be kept in large numbers. Breeding between 
adult zebrafish can be performed once a week, and at each breeding, hundreds of fertilised 
eggs can be collected between a breeding pair. The eggs are fertilised outside of the adult 
fish, and can be collected from the water and taken away for further experiments and 
observation, which is simplified by the fact that the embryos are transparent.  
1.7.1 Conservation of genes 
Though the zebrafish genome is extensively rearranged, there is a great degree of 
conservation between the human and zebrafish genome, with nearly 70% of human genes 
having one or more zebrafish orthologues (Howe et al., 2013). Like humans, zebrafish have 
one copy of CTCF, Smc1, Smc3 and Rad21. Zebrafish do not possess a STAG3 orthologue, 
yet have additional copies of the two human stromal antigens, STAG1 and STAG2, termed 
Stag1a, Stag1b, Stag2a, Stag2b (Howe et al., 2013).  
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Figure 1-5 - Key zebrafish developmental stages. A -One-cell. B – 50% epiboly. C – 13 hours post fertilisation. 
D – 18 hours post fertilisation. Red dotted line marks site for tailbud excision (see method 3.2.14). E – 
Schematic of tailbud structures within the zebrafish tailbud. The tailbud is oriented A-P. Blue – 
Neuromesodermal progenitor population. Yellow – Mesodermal progenitor population. Purple – Neural 
ectoderm. Green – vascular endothelium. Teal – Presomitic mesoderm. Stripes in the presomitic mesoderm 
represent formed somites.  
Zebrafish develop from an embryo to a freely swimming fish over the course of a few days 
(Dooley & Zon, 2000). The zygote remains at the one-cell stage for almost 15 minutes, 
providing a short window of opportunity to inject constructs so that they will be present in 







hours post fertilisation, and the tailbud begins to extend away from the yolk sac at around 
13 hpf (Figure 1-5-C). By ~48hpf, the first fish are beginning to break free from their 
chorions and swim freely. 
1.7.3 The zebrafish tailbud 
The tailbud is an important structure that drives the posterior development of the 
organism. While primary gastrulation generates head structures, the posterior outgrowth 
of the tailbud, and a continual allocation to different cell fates from a bipotent cell pool at 
the very posterior of the tailbud, generates the posterior of the body axis (Smith & 
Kimelman, 2020). The neuromesodermal progenitor cells (NMP’s) are bipotent stem cells 
at the very posterior of the tailbud (Figure 1-5-E ) that escape early gastrulation patterning 
(Attardi et al., 2018; Martin, 2016). These cells remain in a bipotent state during 
somitogenesis, and specify into neural ectoderm and mesodermal progenitors, based upon 
their exposure to Wnt signalling (Dunty et al., 2008; Goto et al., 2017). Sox2, a neural fate 
driver, and Wnt proteins Wnt3a and Wnt8 are present in equal concentrations in the 
NMPs, with brachyury and Wnt engaged in a positive feedback loop to maintain levels of 
Wnt equal to that of Sox2, and thus maintain a bipotent state (Martin & Kimelman, 2012). 
Wnt signalling suppresses the neural fate and drives the mesodermal fate for 
differentiating NMPs (Gouti et al., 2014). When Wnt levels increase in an NMP the cell is 
directed to a mesodermal fate (yellow in figure 1-5-E), and when cells leave the NMP zone 
and are no longer exposed to Wnt signalling, they maintain Sox2 levels and commit to a 
neural fate (purple in figure 1-5-E) (Gouti et al., 2014, 2015; Koch et al., 2017). Cells 
continuously leave the NMP pool as the zebrafish elongates, adding structures to the 
posterior of the developing fish until the NMPs are exhausted and somitogenesis ends 




2 MASTERS OVERVIEW 
This masters research comprises two projects. The first examines a familial RAD21 variant 
and seeks to answer whether this may be linked to observed familial myeloid dysplasia. The 
second examines the role of cohesin in regulating gene expression and cell fate decision 
making in the tailbud during zebrafish embryogenesis.  
 
Both projects utilised the zebrafish strain rad21nz171. This strain carries one truncated rad21 
allele, due to the G227* mutation present. As a total rad21 knockout is lethal, these fish 
are held in heterozygous stocks in the Otago Zebrafish Facility, and in-crossed to produce 
wildtype, rad21nz171 heterozygous and rad21nz171 homozygous siblings.  
2.1 Project one scope: 
The aim of project one was to assay the functionality of the familial S449G RAD21 variant 
identified in the Australian SA Pathology myeloproliferative disorder cohort.  The cohort of 
interest display myeloid dysplasia, and there is potential that this variant RAD21 protein 
could be linked to this prognosis. A Rad21 complementation assay similar to that 
performed in Deardorff et al 2012 will be performed in these analyses to assess if the 
familial variant mRNA produces functional protein and can rescue wildtype-like runx1 
expression in rad21nz171 homozygous embryos. Assigning function to the S449G-RAD21 
variant is essential as it is a familial variant of unknown significance and may be underlying 
the observed myeloid dysplasia in the members of the cohort, with the possibility of 
causing dysplasia in subsequent generations of this family. Identification of S449G RAD21 
functionality, or lack thereof, will bring these families one step closer to identifying what 
may be underlying their family history of malignancy. Alongside the familial variant, a novel 
RAD21 variant will be produced and assayed, giving an opportunity to examine another 





Figure 2-1 - Experimental overview for testing RAD21 functionality. A – Create variant rad21 via site directed 
mutagenesis. B – Transcribe into mRNA. C- Inject variant mRNA into embryos from a rad21nz171 heterozygous 
in-cross. D – Perform runx1 in situ hybridisation. E – Observe phenotype. F – Confirm genotype.  
2.2 Project two scope: 
The aim of project two was to identify the effect that cohesin has on regulating gene 
expression and cell fate commitment in the tailbud of the developing embryo, and how it 
may exert this effect. To identify all of the genes and related developmental pathways 
affected in a cohesin-deficiency, a high-throughput comparative RNA sequencing 
experiment was performed on the tailbuds of wildtype and cohesin deficient siblings from 
a rad21nz171 heterozygous in-cross. Gene expression in the elongating tailbud, which has 
not yet specified into distinct fates was examined with RNA-sequencing, as the posterior of 
the zebrafish develops from this point, making it a hub of transcriptional activity, and a lack 
of cohesin-regulated gene expression is predicted to cause dysregulation and abnormal cell 
fate decisions in this area. A number of the genes identified to be dysregulated in the RNA-
sequencing analyses were examined by in situ hybridisation, to gain a more thorough 
picture of gene dysregulation in cohesin-deficiency. The spatial expression patterns of 
these genes were examined in siblings from a rad21nz171 heterozygous in-cross, and a 
stag1bnz205 heterozygous in-cross, to examine if gene expression phenocopying occurs 








chromatin in cohesin mutants is open to ectopic signals, and thus regulators can have 
access to genes previously sequestered by chromatin organisation. In a bid to explore this 
idea, we utilised the canonical Wnt pathway as a model for all regulators and genes, and by 
agonising the pathway in cohesin-deficiency, we hoped to show that ectopic signals gain 
access to genes in unconstrained chromatin where they can be interpreted and produce 




3 MATERIALS AND METHODS  
3.1 Chemicals and solutions 
All chemicals were of analytical grade. All solutions are listed in Appendix 1. Solutions and 
dilutions were prepared using deionised Milli-Q water (Millipore Corporation) or 
UltraPureTM DNase/RNase-Free Distilled Water (Life Technologies) – here termed 
UltraPure  water.  
3.2 Methods  
3.2.1 Zebrafish  
Zebrafish (D. rerio) were housed and maintained in the Otago Zebrafish Facility. All 
experimental procedures were approved by the University of Otago Animal Ethics 
Committee and carried out in accordance with the Otago Zebrafish Facility Standard 
Operating Procedures.  
3.2.1.1 Zebrafish strains used 
The Rad21 mutant, rad21nz171, Stag1b mutant, stag1b nz205, and 
rad21nz171Tg(7xTCFXla.Siam:nlsmCherry)ia5. 
3.2.1.2 Maintenance and feeding 
Each tank was kept at 24°C - 30°C, pH 6.5 - 8.5 and conductivity of 200 μS - 1000 μS. System 
water was purified using a ZebTEC system. Fish numbers were kept at or below 20 adults 
per 3.5 L tank. Fish were fed three times a day, consisting of two dry feedings and one live 
feed.  
3.2.1.3 Breeding and collecting eggs 
Adult zebrafish were set up in specialised breeding tanks, the afternoon prior to embryo 
collection. These tanks contain a false bottom and a removable barrier to separate male 
and females. The OZF has automated lighting, with lights turning on at 8 am. Removal of 
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the barrier once the lights come on in the morning allows the zebrafish to mate, as the 
innate breeding cue for zebrafish is light. To prevent the parents consuming any eggs, the 
false bottom of the tank allows fertilised eggs to slip through, where they can then be 
collected. Embryos are collected through a fine sieve, and transferred to a petri dish with 
E3 embryo medium supplemented with methylene blue, which acts as an anti-fungal agent.   
3.2.1.4 Growing embryos 
Embryos were grown in a petri dish in E3 medium supplemented with methylene blue. The 
rate of embryo development can be manipulated by incubating at either 28.5°C for normal 
development or slowing down development by incubating at 22.5°C. Embryos hatch 
naturally at 2-3 days post fertilisation, however the chorion can be removed earlier using 
#55 Dumont Forceps. When the chorions were discarded the media was changed to E3 
without methylene blue.  
3.2.1.5 Embryo fixation and storage 
Embryos were collected at the desired developmental stages 13 hpf and 18 hpf (figure 1-5-
C/D),  and the chorions removed manually with forceps. Dechorionated embryos were then 
fixed in 4 % paraformaldehyde (PFA) in 1x PBS at 4 °C overnight. Fixed embryos were then 
dehydrated in 100 % methanol, and stored at −20 °C indefinitely.  
3.2.1.6 Microinjection of zebrafish embryos  
Microinjections of mRNA and morpholino were performed using a Narishige 
micromanipulator (UM-3C) and a MPPI2 Milli-Pulse Pressure Injector under a Leica MZ12 
dissecting microscope. To microinject variant rad21 RNA, 100 pg of each mRNA was 
injected into the one-cell (figure 1-5-A) of embryos from a rad21nz171heterozygote in-cross. 
0.5 pmol of Rad21 morpholino was injected into the yolk sac of 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 embryos at the 1-cell stage. Morpholino oligonucleotides 
(MOs) were obtained from GeneTools LLC and diluted in water. Rad21 MO sequence: 5’-
AGGACGAAGTGGGCGTAAAACATTG- 3’.  
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3.2.2 Riboprobe synthesis 
Maps of all plasmids are shown in Appendix 2. Bulk preps of plasmids containing genes of 
interest were created, and linearised with the appropriate restriction enzymes at 37°C for 2 
h. Digestion was verified by electrophoresis on a 1 % Agarose gel. Linearised plasmids were 
purified via phenol/chloroform protein extraction. To create digoxigenin (DIG) labelled 
riboprobes, the Roche DIG RNA Labelling Kit was used. 1 μg of the purified plasmid DNA 
was used in a transcription reaction mix with either Sp6 or T7 RNA polymerase enzyme 
(Roche Diagnostics), 10x DIG labelled NTP (Roche Diagnostics) and 10x transcription buffer 
(Roche Diagnostics). The eluted riboprobes were quantified using the Nanophotometer and 
run on a 1 % agarose gel to check for quality. All probes were stored at −80 °C, and diluted 
1:100 to give an appropriate probe concentration for in situ hybridisation readout.  
3.2.3 Site directed mutagenesis of zebrafish rad21 constructs  
The QuikChange II Site-Directed Mutagenesis Kit was used to mutagenise the zebrafish 
rad21 gene within PCS2+ rad21 (Appendix 2) after designing primers flanking appropriate 
regions. The kit was followed for generating point mutations, with 12 rounds of PCR 
amplification sufficient to incorporate these into the gene. Following amplification, 1 µL of 
Dpn I restriction enzyme was added to the amplification reactions, consistent with 
manufacturer's instructions, but cell transformation was adapted from manufacturer 
instructions (see method 3.2.4).  
 
Sanger sequencing was performed by Genetic Analysis Otago (http://gas.otago.ac.nz/) to 
confirm that site directed mutagenesis of zebrafish Rad21 was successful. Primers are listed 
in Appendix 3. 
3.2.4 Adapted cell transformation with rad21 constructs  
5 µL of the SDM amplification reactions were added to 500 µL aliquots of XL1-Blue super-
competent cells thawed on ice. The reaction was heat pulsed at 42°C for 45 seconds, then 
placed back onto ice for 2 minutes. 500 µL of SOC broth was added to the tube, then the 
tube was shaken at 37°C for 1 hour. Cells were pelleted by centrifugation at 3000 rpm for 
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10 minutes. All but 100 µL of supernatant was taken off, the pellet resuspended and cells 
plated onto an LB agar + Amp plate. Plates were stored at 37°C for 16 hours. Successfully 
grown colonies were then cultured in 1 mL LB + Amp overnight, and made into a glycerol 
stock by combining 750 µL of overnight culture with 250 µL glycerol, and storing at -80°C.   
3.2.5 Plasmid extraction 
PCS2+ variant-rad21 plasmids were extracted from transformed cells with the Nucleobond 
Xtra Mini Kit for sanger sequencing identification of successful mutagenesis. 
 
Bulk plasmid preps were performed with the Nucleobond Xtra Midi Kit for both plasmids 
containing variant rad21 constructs – to create mRNA from, and plasmids containing genes 
of interest - for riboprobe formation (Appendix 2). Glycerol stocks for all plasmids were 
streaked onto a LB agar + Amp plate, and incubated at 37°C overnight. A single colony was 
then grown at 37°C in a shaking incubator in 5 mL LB + Amp the following night. A bulk prep 
was then grown the following night, by inoculating 100 mL of LB + Amp with 1 mL of the 
overnight culture. This bulk prep was processed with the Nucleobond Xtra Midi Kit, and 
plasmid concentrations measured on the NP80 Nanophotometer 
3.2.6 RNA Synthesis  
Variant and control rad21 mRNAs were synthesised with an SP6 mMessage mMachine 
Transcription Kit according to the manufacturer’s instructions. PCS2+ plasmids containing 
these rad21 constructs (Appendix 2) were linearised with Not I restriction enzyme and 
purified with lithium chloride precipitation before mMessage transcription. All mRNAs 
were resuspended in ultrapure water. Successful mRNA production was visualised by 
running on a 4% agarose gel at 100 V for 20 minutes, and concentration confirmed with 
nanophotometer. 
3.2.7 DNA extraction  
DNA was extracted from adult fin clips and whole embryos by addition of the material to a 
PCR tube containing DNA extraction mastermix (16 µL water and 2 µL of 10x PCR buffer – 
MgCl (Applied Biosystems) per 1x reaction). 2 µL of 10 µg proteinase K was added to each 
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tube, and tubes were incubated at 50 minutes at 50°C, 10 minutes at 98°C, and then cooled 
to 4°C, where stored until required.  
3.2.8 TaqMan genotyping  
Following DNA extraction, the TaqMan rad21nz171 mutation assay was performed by adding 
1 µL of DNA extraction mix to 19 µL of TaqMan mastermix (10 µL 2x KAPA hotstart 
polymerase, 8.5 µL H20 and 0.5 µL 40x SNP mix (which contains two fluoro-probes, that 
bind to the different alleles respectively) per 1x reaction). The automated programme 
“Taqman_meier_kapa” was run on the LightCycler480 software to identify between 
mutant and wildtype alleles at the rad21nz171 locus. The mutant rad21nz171 allele binds the 
FAM probe (465-510nm) and the wildtype allele binds VIC (533-580nm), making a 
distinction between the genotypes clear.  
3.2.9 Reporter line genotyping 
Following DNA extraction, 1 µL of DNA extraction mix was added to 9 µL of PCR mastermix 
(1 µL of 10x PCR buffer (-MgCl), 0.3 µL of MgCl2, 50 mM, 0.2 µL of dNTP mix, 10 mM, 7.06 
µL of nuclease-free water, 0.04 µL of Platinum Taq DNA Polymerase, and 0.2 µL of each 
mCherry forward and reverse primer per 1x reaction) and run on the Thermocycler at 94 °C 
for 3 minutes, thirty cycles of : 94°C for 30 seconds, 57°C for 30 seconds and 72°C for 30 
seconds, 72°C for 7 minutes, before cooling at 4°C indefinitely. The PCR product was then 
run on a 1% agarose gel for 120 V for 1 hour, and imaged using a GelDoc (Biorad). If a 
product was visualised, the fish carries the reporter gene.  
3.2.10 HRMA genotyping   
Following DNA extraction, 1.2 µL of DNA extraction mix was added to 9 µL of mastermix 
(2.55 µL water, 1.2 µL 25 mM MgCl2, 5 µL 2x HRMA kit master mix and 0.125 µL of each 
forward and reverse primer per 1x reaction) and run on the LightCycler at 95 °C for 5 
minutes, 40 cycles of: 95°C for 10 seconds, 60°C for 15 seconds, and 72°C for 20 seconds, 
before cooling to 37°C. Genotypes were interpreted from the melt curves, as the 
heterozygotes separate from the homozygotes distinctly, and homozygous mutants can be 
identified in comparison to homozygous wildtype controls.  Primers listed in Appendix 3. 
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3.2.11 Whole-mount in situ hybridisation and preparation for imaging 
For in situ hybridisation of embryos, both overnight hybridisation and wash steps were 
performed at 65°C. Washes were performed as follows: 25% 2×SSCT/75% hybe-buffer,   
50% 2×SSCT/50% hybe-buffer,  75% 2×SSCT/25% hybe-buffer,  100% 2×SSCT (15 minutes),  
0.2×SSCT (2x30 minutes), PBST (3x5 minutes). Embryos were blocked in 2% blocking 
reagent for 2-3 hours. Riboprobes were detected with anti-DIG antibodies coupled to 
alkaline phosphatase (AP). Excess antibody was removed by 8x15 minute PBST washes. 
Bound antibody was visualised using the AP substrate NBT/BCIP. Once the stain developed, 
embryos were washed 3x5 minutes in PBST to stop further stain development, then fixed in 
PFA overnight. PFA cleared with 2x5 minute PBST washes, then the prepared embryos 
stored in 80% glycerol at 4°C until ready for imaging.  
3.2.12 Imaging in situ embryos 
Embryo images were captured on a Leica M205FA microscope using a Leica DFC490 camera 
linked to Leica Application Suite V4 software. A dimpled slide was used to manipulate 
embryos in glycerol for imaging. As embryos could not be sorted into their respective 
genotype by morphology alone, they were genotyped post-imaging. 
3.2.13 Stimulating embryos with WNT agonist 
Rad21nz171 Tg(7xTCFXla.Siam:nlsmCherry)ia5 fish were in-crossed and the collected 
embryos grown until 50% epiboly, at which the chorion was torn, and embryos added to 
the well of a 24-well plate and immersed in 600 µL of E3 supplemented with 2.5uM of BIO. 
The embryos were then grown until 18 hpf, at which point their mCherry fluorescence was 
examined with the Nikon C2 confocal microscope, and associated NIS imaging software.  
3.2.14 Tailbud excision 
rad21nz171 heterozygote fish were in-crossed, and the embryos grown until 18 hpf. Each 
embryo was manually dechorionated with Dumont 55 forceps, and using the forceps, the 
tailbud was dissected away from the rest of the embryo. The dissected tailbud was 
dissolved in 3 µL of RLT + BMe (Qiagen RNeasy) in a PCR tube, and stored at -80 °C, while 
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the top half of the embryo was placed in 18 µL of DNA extraction mix (see method 3.2.7) in 
a separate PCR tube with a matching label. DNA was extracted from the top half of the 
embryo, and TaqMan genotyped, providing the genotype of the stored tailbud, as 
genotypes cannot be inferred from morphology at 18 hpf. Sibling wildtype and rad21nz171 
homozygote embryos were used for comparison, and 4x pools of 80 tailbuds were 
collected for each genotype. Rad21nz171 heterozygote tailbuds that were inadvertently 
collected were not used for analysis. 
3.2.15 RNA extraction 
RNA was extracted from pooled tailbud samples using the Qiagen RNeasy Micro kit. The 
manufacturer’s instructions were followed, with some optimisation of the process. All 
buffers were warmed to 23°C before use, and buffer RDD was warmed to 30°C before use. 
During the RPE wash step, tubes were rolled horizontally back and forth for 30 seconds to 
ensure guanine salts (present in RLT) would not contaminate the final elution. Samples 
were analysed by Qubit, Bioanalyser, and nanophotometer to ensure no there was no RNA 
degradation and that sufficient quantities were present for sequencing. 
3.2.16 RNA-Sequencing  
RNA samples comprising four pools per condition from rad21nz171 homozygote and 
wildtype tailbuds (n=80 per pool) were sequenced to compare gene expression profiles. 
TruSeq stranded mRNA libraries were prepared by Genomics Otago, and paired end 2x50 
base pair sequencing was performed on an Illumina HiSeq 2500 V2. Between 40 and 55 
million reads were generated for each replicate. 
3.2.17 RNA-sequencing analysis 
Gregory Giminez assisted with analyses. Using FastQ-Mcf tools, the reads were adaptor and 
quality trimmed and sequences with a Phred score lower than Q20 were removed. The 
cleaned reads were aligned against zebrafish genome version GRCZ11 using HISAT2 version 
2.0.5. The reference genome was indexed before alignment. Read counts were retrieved 
first by exon and then summarised by gene using FeatureCount, only reads with a mapping 
quality of 10 were taken into account to avoid spurious alignment. Euclidean distance 
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matrices and PCA analysis confirmed clustering of distinct conditions. A normalised Bland 
Altman MA plot identified dysregulated genes, and reactome and gene ontology pathways 
analyses identified dysregulated pathways between the conditions. Identities for the top 50 
most dysregulated pathways were manually plotted to provide visualisation of 
dysregulation in rad21nz171 homozygote samples.  
3.2.18 Protein prediction  
PyMOL and STRUM software was used for protein alignments and an annotate script 
written by David Markie (Department of Pathology, University of Otago) which utilised 
BCFtools (v1.9) adding metrics Polyphen-2, MPC, REVEL and PrimateAI, was used to predict 
pathogenicity of rad21 variants. 
3.2.19 Other software 
Biorad GelDoc XR+ with Quantity One imaging software used for all gel images. NP80 




4 ASSAYING FUNCTIONALITY OF RAD21 VARIANTS 
Injections of variant rad21 mRNA into rad21nz171 homozygote embryos and subsequent 
runx1 in situ hybridisation at 13 hours post fertilisation allows identification of the 
functionality of the variant, as a functional rad21 mRNA will rescue runx1 expression in the 
haematopoietic mesoderm, while non-functional rad21 mRNA will not (Deardorff et al., 
2012). The functionality of familial S449G-RAD21 was assayed alongside a novel variant 
that was designed for these analyses, I152F-RAD21, which has not been identified in any 
cohorts to date. The novel variant I152F was produced at the opposite end of the RAD21 
gene to S449G and introduced a large phenol group to the protein, in a bid to create 
protein folding changes or steric hindrance at the binding interface with SMC3. 








change in human 
RAD21 
Novel A742T ATC > TTC (I>F) I152F 
Familial A1346G AGU > GGU (S>G) S449G 
Table 4-1 - Creating amino acid changes in RAD21 via a single nucleotide change. The single nucleotide 
variation, along with the codon and amino acid changes that result are outlined for both the novel and 
familial variants. 
Table 4-1 shows both the familial and novel variants, and which amino acids change 
because of these single nucleotide variations. To maintain consistency throughout, the 
variants will be referred to by their amino acid changes in the human RAD21 gene, I152F 




Figure 4-1 - Creating human RAD21 mutations in the zebrafish rad21 gene. Top: Alignment of human RAD21 
and zebrafish rad21, with I152F and S449G annotated in orange. Middle: Variant-flanking primers designed to 
incorporate the point mutations, shown as green annotations spanning the orange sites of variation. Bottom: 
Alignment of rad21 and sequencing files for S449G-rad21 and I152F-rad21 after successful site-directed 
mutagenesis.  
Human RAD21 and zebrafish rad21 were aligned in Geneious and the I152F and S449G 
variants of interest annotated at the analogous sites in rad21 (Figure 4-1 – Top). Primers 
were designed for the PCS2+-rad21 plasmid (Appendix 2) flanking the sites which were to 
have the appropriate point mutations inserted, and site directed mutagenesis (SDM) 
performed.  
4.1.1 Optimisation of SDM for the S449G-rad21 variant 
Sanger sequencing confirmed that the SDM process was successful in producing the I152F 
variant in rad21 immediately. However, SDM had to be optimised for the S449G variant, as 
the kit-directed twelve rounds of PCR amplification did not incorporate the S449G 
mutation. Sixteen rounds of amplification were performed with a gradient of annealing 
temperatures, and 57 °C was found to be optimal for the PCR reaction. Subsequent Sanger 
sequencing confirmed the production of the S449G-rad21 variant.  
 
Successful production of variant plasmids allowed for control and variant rad21 mRNA 
transcription. The mRNA integrity was confirmed as suitable for the runx1 in situ bioassay 
(Appendix 4).  
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4.2 Assaying phenotype and confirming genotype 
 
 
Figure 4-2 - Assaying rad21 phenotype and genotype. A – Representative image of a rad21nz171 homozygote 
embryo following runx1 in situ hybridisation at 13 hpf. B – Representative image of a wildtype-like embryo 
following runx1 in situ hybridisation at 13 hpf. Runx-1 is expressed in Rohon-Beard neuronal progenitors (RB) 
and haematopoietic mesoderm (HM). C - TaqMan analyses chart demonstrating clear distinction between 
wildtype (rad21+/+), rad21nz171 heterozygote (rad21+/-), and rad21nz171 homozygote (rad21-/-) samples at the 
rad21nz171 variant site in rad21 (as labelled). Negative control also shown. The mutant allele binds to the 465-
510 fluorophore (x axis) while the wildtype allele binds to the 533-580 fluorophore (y axis). 
A 1:100 riboprobe dilution produced specific runx1 staining with little background, which is 
imperative for effective phenotyping of embryos. rad21nz171 homozygote embryos express 
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runx1 in the Rohon Beard neurons (RB), but not in the haematopoietic mesoderm (HM) 
(Figure 4-2-A). Both wildtype and rad21nz171 heterozygote embryos express runx1 in the RB 
and the HM, an expression pattern termed “wildtype-like” for these analyses (Figure 4-2-
B). TaqMan genotyping distinguishes between wildtype and rad21nz171 heterozygote 
embryos, which cannot be distinguished phenotypically (Figure 4-2-C). Once rad21 mRNA 
microinjections are performed, and functional Rad21 protein produced, runx1 staining in 
the HM of rad21nz171 homozygote embryos is rescued, and they too have a wildtype-like 
phenotype. TaqMan genotyping is therefore imperative to distinguish if  wildtype-like 
embryos are producing their own Rad21 protein, or gaining Rad21 functionality through 
microinjected rad21 mRNA. Due to Mendel’s law of independent assortment, only 25% of 
the embryos from the rad21nz171 heterozygous in-cross will be rad21nz171 homozygous, and 




4.3 Assaying RAD21 functionality 
 
 
Figure 4-3 - Determining runx1 rescue in rad21nz171 homozygote embryos. Representative images of wildtype-
like rad21nz171 homozygote embryos following injection with rad21 mRNAs at the 1-cell stage, followed by 
runx1 in situ hybridisation at the 13 somite stage. A - rad21 injected embryos, B - rad21nz171 injected embryos. 
C- S449G-rad21 injected embryos, D- I152F-rad21 injected embryos. Numbers in the bottom right reflect the 
number of rad21nz171 homozygote embryos that produced wildtype-like runx1 expression due to functional 
rad21 mRNA injection. Rohon-Beard neuronal progenitors (RB) and haematopoietic mesoderm (HM) runx1 
expression labelled.  
Rad21 and rad21nz171 mRNA were microinjected as positive and negative controls 
respectively, to establish the Rad21 complementation assay. Rad21 injections restored HM 
runx1 staining in 10/12 rad21nz171 homozygote embryos while rad21nz171 injections could 
not rescue runx1 expression in any of the 17 rad21nz171 homozygote embryos injected, 
confirming that the bioassay was effective in determining Rad21 functionality . The two 
rad21nz171 homozygote embryos injected with wildtype rad21 mRNA that did not exhibit 




Variant rad21 mRNA was assayed and rescue determined. S449G-rad21 was effective in 
rescuing runx1 HM expression in 35/37 rad21nz171 homozygote embryos (Figure 4-3-C), with 
the 2 rad21nz171 homozygote embryos not rescued predicted to be due to microinjection 
error. Successful HM runx1 rescue shows that the S449G variant is functional, at least for 
rescuing runx1 gene expression. I152F-rad21 mRNA did not rescue runx1 HM expression in 
the 33 rad21nz171 homozygote embryos injected, indicating that this novel variant is non-
functional during development (Figure 4-3-D). 
4.4 Predicting 3D protein structure of the variants 
The novel I152F variant was designed to result in an isoleucine to phenylalanine 
substitution, which changes the properties of the amino acid from aliphatic to aromatic, as 
it adds a large phenol group to the structure.  The familial S449G conversion does not 
drastically change the size of the amino acid, but changes the site from hydrophilic to 
hydrophobic, which could affect how the protein folds in 3D.  If either of the variants amino 
acid changes result in the final protein folding differently, this could affect the ability of 
RAD21 to interact with other cohesin subunits, and compromise cohesin functionality. 
Currently, there is no complete RAD21 crystal structure. STRUM analyses generated a 
proposed 3D structure of the variant RAD21 proteins, to determine if the I152F or S449G 
variant sites lie within binding or active domains of the RAD21 protein. The two STRUM 
predictions have an identical 3D shape (Appendix 4), which indicates that the amino acid 
changes do not result in dramatic protein folding changes. The STRUM predictions 
indicated that I152F may be located within one of the SMC3 ATPase binding domains 
(Appendix 4). Steric hindrance at the ATPase binding site could disrupt cohesion complex 






Figure 4-4 - Schematic of proposed variant sites within RAD21. Schematic of Rad21 interactions with other 
cohesin subunits. Existing RAD21 crystal structures 4UX3 and 6RRK are circled in black. Predicted variant sites 
within Rad21 labelled with yellow and teal stars.  
There are several 3D structures in the Protein Data Base (PDB) that contain fragments of 
RAD21, where it is bound to other cohesin subunits. These structures were aligned to the 
variant RAD21 amino acid sequences in PyMol, to establish if the I152F variant interacts 
with the SMC ATPase head, as the STRUM prediction indicated. It was clear that it did not. 
Figure 4-4 depicts the predicted variant sites in relation to the known crystal structures. 
4UX3 is an existing structure of the SMC3 ATPase head bound to RAD21, and 6RRK is the 
STAG1 subunit in complex with the middle portion of RAD21. The variants of interest are 
not contained within these known fragments of RAD21, but with mapping of their amino 
acid position it was determined where they may be located within the 3D protein. I152F is 
located towards the SMC3 binding domain, but between where SMC3 binds and where 
STAG binds. S449G is located towards the SMC1 binding domain, but between where SMC1 






What it shows S449G I152F 





MPC  How “bad” a missense variant is 
a 0-5 scale (5 being very bad), 
scores >2 are enriched for 







REVEL This one is extremely 
conservative, with a score >0.6 






Primate AI Scores >0.8 are typically used 





Table 4-2 - Pathogenicity predictions from a number of different programmes. 
The variant amino acid sequences were analysed with a number of different pathogenicity 
prediction pipelines, and the outcomes are depicted in Table 4-2. Most of the pipelines 
predicted that S449G-RAD21 would be benign, yet there were conflicting results amongst 
the different programmes about the pathogenicity of I152F-RAD21. PolyPhen-2 and REVEL 
predicted I152F to be benign, while MPC and Primate AI predicted it to be pathogenic. 
4.5 Conclusion 
This experimental design was used due to its previous success in uncovering RAD21 
functionality in a developmental context (Deardorff et al, 2012). It was important to 
discover the functionality of the familial S449G-RAD21 variant as it is of unknown 
significance, yet may play a critical role in the development of myeloid dysplasia, which is 
observed in this family. We have determined that S449G-RAD21 is functional, at least in 
early developmental stages, as analogous zebrafish S449G-rad21 mRNA was sufficient to 
rescue a wildtype-like phenotype in rad21nz171 homozygote embryos. The novel variant 
I152F-RAD21 does not produce a functional cohesin subunit, as no haematopoietic 
mesoderm runx1 expression was rescued in rad21nz171 homozygotes injected with I152F-
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rad21 mRNA. Mapping existing fragments of RAD21 allowed identification of a generalised 
location of the variant sites within the 3D protein. Neither of the variants appear to be 
located in direct binding domains of RAD21 to other cohesin subunits, but this does not 
mean that they are not capable of causing steric hindrance in cohesin complex formation. 
Pathogenicity programmes and STRUM, a protein prediction programme, both highlighted 
that though algorithms are a great indicator of what may be happening biologically, they 
are not as accurate and as informative as functional assessment. Taken together, the 




5 COHESINS ROLE IN REGULATING DEVELOPMENTAL GENE EXPRESSION 
To gain a broad understanding of gene expression patterns and cell fate decisions  in 
cohesin-deficient development, a tissue-specific RNA-sequencing experiment was 
performed, analysing genes expressed in the developing zebrafish tailbud. In this 
experiment, averaging effects across the whole embryo would not interfere with 
sequencing readout, as they may have in previous studies (Meier et al., 2018). The tailbud 
is a fascinating component of the zebrafish embryo, as it elongates away from the yolk sac 
as development progresses, contributing to multiple essential structures. We aimed to 
identify which genes and pathways cohesin controls in the developing zebrafish tailbud. 
5.1 RNA-sequencing experimental overview 
 
Figure 5-1 - Outline of the comparative RNA-sequencing experiment. Genotypes denoted on diagram as 
follows: Wildtype – Rad21+/+, Rad21nz171 heterozygote – Rad21 +/-, Rad21nz171
 
homozygote – Rad21 -/-. 
Rad21nz171
 
heterozygote embryos in-crossed and the embryos grown until 18 hours post fertilisation. At 18 
hours post fertilisation, the tailbud was dissected away from the embryo, and stored in a labelled tube. 
Genotypes  cannot be inferred from morphology at this stage, therefore the top half of the embryo was 
TaqMan assayed to identify the genotype of the stored tailbuds, which were then pooled in groups of 80, 4x 





Sample  Concentration (ng/μl) RIN number 
Rad21nz171 homozygote 1 (M1) 113.7 9.1 
Rad21nz171 homozygote 1 (M2) 79.5 9.1 
Rad21nz171 homozygote 1 (M3) 97.8 9.0 
Rad21nz171 homozygote 1 (M4) 81 8.8 
Wildtype (WT1) 80.1 8.8 
Wildtype (WT2) 79.5 9.7 
Wildtype (WT3) 75.6 9.1 
Wildtype (WT4) 99.9 6.5 
Table 5-1 - RNA quality measurements. Samples are listed with respective concentrations and quality 
measurements. 
The process of collecting wildtype and cohesin deficient tissue for examination is outlined 
in Figure 5-1. Any rad21nz171 heterozygote tissue that was inadvertently collected during 
the process was not sequenced in these analyses. Preliminary mRNA quality data is 
outlined in Table 5-1. Sufficient quantities of RNA were extracted, and this RNA was not 
degraded, as determined by the high RIN numbers, making it suitable for RNA-sequencing.    
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5.2 Confirming read depth  
 
 
Figure 5-2 - Bar graph depicting the number of reads per RNA-sequencing replicate 
All replicates had consistent read depth, which highlighted that the experimental work 
preceding the analyses was clean and that despite the cohesin-deficiency, mutant embryos 
still efficiently express genes . With at least 40 million reads per replicate, there was ample 




5.3 Rad21 expression and verification of mutation 
  
  
Figure 5-3 - Confirming loss of rad21 expression in rad21nz171 homozygotes. Both panels depict the 60 
nucleotides surrounding the G>T base pair change which produces the null rad21 allele. Top panel – 
Expression of rad21 in wildtype (blue) and rad21nz171 homozygote (red)samples. Grey histogram depicts read 
depth. Bottom panel – A close up of the read depth surrounding the G>T base pair change which produces the 
null rad21 allele, in rad21nz171 homozygote samples. Grey depicts the functional rad21 allele read depth and 
green depicts the null rad21 allele read depth.   
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It is clear that rad21 expression is greatly reduced in rad21nz171 homozygote samples 
compared to wildtype. (Figure 5-3 – Top panel). There are at least 3000 copies of rad21 
mRNA in each of the wildtype replicates, yet less than 300 in each of the rad21nz171 
homozygote replicates. Upon closer examination of the small amount of rad21 transcript 
present in the rad21nz171 homozygote samples, it became apparent that there is residual 
maternally deposited rad21 present, as the rad21nz171 homozygote embryos cannot 
produce the functional allele, only the null allele, of which small amounts of transcription 
were also observed (Figure 5-3 – Bottom panel). The presence of maternally-deposited 
rad21 mRNA reflects previous findings in which rad21 mRNA was detected by RT-PCR in 
rad21nz171 homozygotes early in embryogenesis and immunoblotting showed Rad21 
presence in rad21nz171 homozygotes at 18 hpf (Horsfield et al., 2007). The low levels of 
rad21nz171 mRNA present in the homozygotes is likely due to nonsense mediated mRNA 
decay, as the null allele produces a stop codon in the gene. The exact amount of functional 
rad21 transcript present in the rad21nz171 homozygote samples was between 0-74 copies. 
As these were pools of 80 tailbuds it is evident that there is almost negligible maternal 
rad21 left at 18 hpf and it is therefore likely inefficacious on gene expression from this time 




5.4 Confirming distinction between the samples 
 
 
Figure 5-4 - Determining relatedness of replicates based upon gene expression profiles. Top - Euclidean 
distance matrix visualising genetic distance and relatedness between replicates. The four wildtype replicates 
are depicted in blue, and the four rad21nz171 homozygote replicates, in red. Tree diagram shows the 
relatedness of the eight replicates. The alignment of the distance tree against itself demonstrates how similar 
gene expression is between groups, the darker the coloured box, the more similar the gene expression. Bottom 
- PCA plot, also demonstrating similarity between replicates. The four wildtype replicates are depicted in blue, 
and the four rad21nz171 homozygote replicates, in red. 
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Both the distance matrix and the PCA plot analysis demonstrate that the four replicates for 
each condition are closely related, yet dissimilar to the other condition (Figure 5-4; further 
PCA plots in Appendix 4). The four wildtype replicates clustered together on the distance 
matrix tree, as did the four rad21nz171 homozygote replicates. The two distinct groups 
clustered separately from one another.  Self-alignment of the tree showed that gene 
expression profiles in wildtype replicates are similar to each other and dissimilar from 
rad21nz171 homozygote replicates, and vice versa. The PCA plot shows distinct clustering of 
the replicates for each condition, as well as separation between the wildtype and rad21nz171 
homozygote samples, reinforcing that these replicates are suitable for comparative 
analyses. 
5.5 Analysing differential gene expression 
 
Figure 5-5 - MA plot of differential gene expression in rad21nz171 homozygote replicates  compared to 
wildtype replicates. The log fold change is plotted on the y axis, and the normalised expression signal is 
plotted on the x axis. All points on the plot are differentially expressed genes. Red points are significantly 
differentially expressed in rad21nz171 replicates compared to wildtype replicates. Corrected for multiple testing 




As the MA plot demonstrates, there were an abundance of genes significantly dysregulated 
in rad21nz171 replicates compared to wildtype (red points in figure 5-5). After applying 
statistical testing, there are 1988 genes that are up-regulated, and 2332 genes that are 
downregulated in rad21nz171 homozygote replicates compared to wildtype. This abundance 
of identified genes highlights how important cohesin is for normal gene expression and 
development.  
 
It is expected to observe differential gene expression across the genome, which occurs by 
random chance, but statistical analysis of gene dysregulation per chromosome showed a 
significant increase on chromosome 12 and 16 (Appendix 4). Interestingly, the rad21 gene 
is on zebrafish chromosome 16.  
 
A number of the genes that were identified in these analyses had also been identified in 
rad21-deficient embryos at an earlier time point by Meier et al., warranting closer 
investigation. By analysing how these genes are expressed, by in situ hybridisation, 
quantitative data can be merged with visual data, allowing a better understanding of how 
these genes are dysregulated in a cohesin-deficiency.  Both rad21-deficient and stag1b-
deficient zebrafish embryos were assayed via in situ hybridisation. By comparing 
deficiencies in two different cohesin complex subunits, we aimed to examine if gene 
expression phenocopying occurs, or if the deficiencies in different subunits produce 
different expression patterns altogether. Heterozygous lines of rad21nz171 and stag1bnz205 
fish were in-crossed to produce wildtype, heterozygous and homozygous mutant sibling 
offspring for fair gene expression comparison of wnt3a, sema3ab, has2 and pax2a. All four 
of these genes were identified as significantly dysregulated in the RNA-sequencing 
analyses. Wnt3a was chosen to examine because it is a master regulator of axial elongation 
and sema3ab, has2 and pax2a have been identified in previous research. 
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5.5.1 Expression of wnt3a gene 
 
 
Figure 5-6 - Expression of wnt3a in wild type, heterozygote and homozygote rad21nz171 and Stag1bnz205 
embryos at the 18-somite stage. A. Wildtype B. rad21nz171 heterozygote C. rad21nz171 homozygote D. Wildtype 
tailbud zoom E. rad21nz171 heterozygote tailbud zoom F. rad21nz171 homozygote tailbud zoom G. Wildtype H. 
stag1bnz205 heterozygote I. stag1bnz205 homozygote. Brain structures = b, neural crest cells = nc, tailbud = tb, * 
indicates a potential reduction in expression.  
 
Wnt3a was identified as significantly downregulated in the tailbuds of rad21nz171 
homozygote embryos compared to their wildtype siblings in the RNA-sequencing analysis. 
The in situ gene expression patterns were not significantly different between Wild type, 
heterozygote and homozygote rad21nz171 and stag1nz205 embryos, as they all expressed 
wnt3a in the tailbud, the developing brain, and neural crest cells (Figure 5-6). Wnt3a 
tailbud expression was analysed at a higher magnification in rad21nz171 embryos, as whole 
embryo images (Figure 5-6 – A,B,C) indicated that there may be differential levels of wnt3a 
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tailbud expression between the genotypes. The star in figure 5-6 – C indicates a potential 
reduction in wnt3a expression in the tailbud of Rad21-deficient embryos, compared to 
those with functional cohesin. A second in situ hybridisation analysis was performed on 
another rad21nz171 heterozygous in-cross, and the tailbuds examined more closely. There is 
an observable decrease in tailbud wnt3a expression when an embryo is Rad21-deficient, 
rad21nz171 homozygote embryos (Figure 5-6-F) have patchier and diminished wnt3a levels 
compared to wildtype (Figure 5-6-D). 
5.5.2 Expression of sema3ab gene 
 
Figure 5-7 - Expression of sema3ab in wild type, heterozygote and homozygote rad21nz171 and stag1bnz205 
embryos at the 18-somite stage. A. Wildtype B. rad21nz171 heterozygote C. rad21nz171 homozygote D. Wildtype 
E. stag1bnz205 heterozygote F. stag1bnz205 homozygote. Craniofacial structures = c, neural crest cells = nc, 
somites = s, eye = e. * indicates an increase in expression in posterior somites. 
Sema3ab was identified as one of twelve semaphorin signalling molecules significantly 
downregulated in rad21nz171 homozygote tailbuds compared to tailbuds of their wildtype 
siblings, while another six semaphorin molecules were significantly up-regulated, making 
these genes crucial to examine spatially. The in situ gene expression patterns showed that 
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sema3ab is expressed in the craniofacial region, eye, somites and neural crest cells of 
wildtype and heterozygote rad21nz171 and Stag1bnz205 embryos (Figure 5-7 – A,B,D,E), 
making these genotypes almost indistinguishable by their sema3ab expression. Both 
stag1bnz205 and rad21nz171 heterozygotes appeared to have a reduction in sema3ab 
expression in the craniofacial region compared to their wildtype siblings yet retained 
expression in the eye. Rad21nz171 homozygote embryos had no sema3ab expression in the 
somites or the eye but retained expression in the neural crest cells (Figure 5-7 – C). 
Stag1bnz205 homozygote embryos had reduced sema3ab expression in the eye but retained 
expression in the neural crest cells and had increased expression in the somites, indicated 
by the * in Figure 5-7. Homozygous rad21nz171 and stag1bnz205 embryos were easily 
distinguishable from their siblings by sema3ab expression. Sema3ab signalling is important 
to guide neural crest cells into the pharyngeal arches, which will go on to form the upper 
and lower jaw, the face and palate (Yu & Moens, 2005), which explains the wide 
distribution of sema3ab around the eye and brain of the developing embryos. The 
semaphorin family of signalling molecules guide migration of a number of cell type, which 
could explain the expression seen in posterior somites (Nakamura et al., 2000).   
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5.5.3 Expression of has2 gene 
 
Figure 5-8 - Expression of has2 in wild type, heterozygote and homozygote rad21nz171 and stag1bnz205 
embryos at the 18-somite stage. A. Wildtype B. rad21nz171 heterozygote C. rad21nz171 homozygote D. Wildtype 
E. stag1bnz205 heterozygote F. stag1bnz205 homozygote. Heart = h, tailbud = tb. 
Has2 was identified as significantly downregulated in the tailbuds of rad21nz171 homozygote 
embryos compared to their wildtype siblings, Has2 was expressed in the tailbud and the 
heart of wild type, heterozygote and homozygote stag1bnz205 embryos (Figure 5-8 – D,E,F) 
and wild type and heterozygote rad21nz171 embryos (Figure 5-8 – A,B), making these 
genotypes indistinguishable by their has2 expression. Rad21nz171 homozygote embryos had 
diminished has2 expression in the tailbud, and no expression in the heart, making them 
easily distinguishable from their siblings by has2 expression (Figure 5-8 – C). Has2 is 
essential for producing hyaluronan, a critical component of extracellular matrices and a 
major component of the cardiac jelly, which is critical for valve development (Just et al., 
2016). In rad21nz171 homozygote embryos all heart has2 expression was lost, consistent 
with improper heart valve formation (Schuster et al., 2015). The reduction in tailbud has2 
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expression of rad21nz171 homozygotes also indicates a breakdown of other essential 
structures which require strong extracellular matrices. 
5.5.4 Expression of pax2a gene 
 
Figure 5-9 - Expression of pax2a in wild type, heterozygote and homozygote rad21nz171 and stag1bnz205 
embryos at the 18-somite stage. A. Wildtype B. rad21nz171 heterozygote C. rad21nz171 homozygote D. Wildtype 
E. stag1bnz205 heterozygote F. stag1bnz205 homozygote. Midbrain-hindbrain boundary = mhb, optic stalk = os, 
otic vesicle = otv, pronephric duct = pd. 
 
Pax2a was identified as significantly upregulated in the tailbuds of rad21nz171  homozygote 
embryos compared to their wildtype siblings. Pax2a was expressed in the developing eyes, 
brain, heart, spinal cord neurons and pronephric ducts of wild type, heterozygote and 
homozygote stag1bnz205 and rad21nz171 embryos (Figure 5-9), making these genotypes 
indistinguishable by their pax2a expression. Pax2a is a transcription factor involved in the 
development of a number of organs throughout embryogenesis, including the eye, kidney 
and the nervous system, which explains strong expression identified in these structures . 
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Though no differences were observed at this time point, it is established that pax2a gains 





5.6 Pathway analyses 
 
Figure 5-10 - Reactome pathway plot depicting the top 15 enriched pathways within the down regulated 
genes in rad21nz171 homozygote samples. 
No biological pathways were enriched within the up-regulated genes in rad21nz171 
homozygote samples. In comparison, 25 pathways were significantly enriched in down-
regulated genes, with the top 15 depicted in figure 5-10. RNA processing was identified as 
extremely dysregulated in rad21nz171 homozygote samples. Many of the small nuclear 
ribonucleoprotein (snRNP) and pre mRNA processing factor (prpf) genes, which control 
mRNA splice site recognition and regulate alternative mRNA splicing were significantly 
downregulated, along with nup107, a nucleoporin gene, which allows mRNA transport 
from the nucleus. The cell cycle was also  identified as extremely dysregulated in rad21nz171 
homozygote samples, with key cell cycle regulators such as cdk1 amongst a number of 
cyclin genes significantly downregulated in these samples. rgcc, the regulator of the cell 
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cycle, was also significantly downregulated in rad21nz171 homozygote samples. rgcc 
increases the kinase activity of the cyclin proteins, allowing progression of the cell cycle. 
Five of the six genes that make up the minichromosome maintenance protein complex 
(MCM) were significantly downregulated, and thus MCMs role in cell cycle DNA replication 
is likely deficient in rad21nz171 homozygotes.  The reactome analyses are a database of 
reactions, pathways and biological processes, they are not cell type specific, or organ 









Figure 5-11 - Metascape analyses of significantly dysregulated pathways in rad21nz171 homozygotes. Top: 
Metascape pathway enrichment for genes up-regulated in rad21nz171 homozygote samples compared to 
wildtype. Bottom: Metascape pathway enrichment for genes down-regulated in rad21nz171 homozygote 




Metascape analyses group genes into function-relevant annotations, and identified neural 
system development pathways to be the most significantly upregulated in rad21nz171 
homozygotes compared to wildtype. A large number of genes associated with neural tube 
formation and closure were upregulated, such as ccdc85b, scrib, pcdh19 and neo1a. Nrp2b, 
a binding factor for the semaphorin family was upregulated, along with a number of other 
signalling molecules crucial for axon guidance and neural crest cell migration. 
 
A varied list of pathways were just as significantly downregulated, including DNA and RNA 
processing and cell cycle control, as identified in Reactome analyses. Interestingly, 
Metascape identified ribosome biogenesis as the most significantly downregulated 
pathway in rad21nz171 homozygotes. RNA processing and ribosome biogenesis are not 
currently well-established roles for cohesin within a cell, and warrant further examination. 
Along with the genes identified as key in the processing of pre-mRNA, genes involved in 
formation of the ribosome, which will translate the mRNA into functional protein, were 
also significantly downregulated. The ribosome protein large (rpl) genes were abundantly 
downregulated, as were the dead box (ddx) genes, which arrange ribonucleoprotein 
complexes. nmd3 and eif6, two genes involved in exporting ribosomal subunits from the 






Figure 5-12 - Pie charts demonstrating the breakdown of pathway identities in the top 50 up and down 
regulated pathways enriched in rad21nz171 homozygote samples compared to wildtype. Top – 
Downregulated pathways. Bottom – Upregulated pathways  
Of the top 50 most significantly up-regulated pathways in rad21nz171 homozygote samples, 
most were non-specific, but a significant portion were related to neural system 
development, while another portion were related to embryo patterning. In comparison, of 
the 50 most significantly down-regulated pathways, many more specific processes were 
affected, rather than generalised developmental pathways. Most significantly, RNA and 
DNA processing pathways were downregulated, as were pathways related to forming 
mesodermal systems. Embryo patterning pathways were also downregulated. Together 
these data indicate that when an embryo is Rad21 deficient, on top of expected 
dysregulation in cell cycle pathways and DNA processing, there is a shift from mesodermal 




Previous work by Farrell et al involved single cell sequencing of zebrafish embryos, and 
applying a computational approach to describe the transcriptional profiles of a number of 
distinct cell trajectories. This work was carried out in zebrafish embryos from 3 hours post 
fertilisation to 11.5 hours post fertilisation (Farrell et al., 2018). Though our analyses 
examined gene expression profiles at 18 hours post fertilisation, the dysregulated gene lists 
were compared to Farrell trajectory lists, to determine if any general trends in trajectory 
dysregulation were still relevant. A large number of the genes identified in these analyses 
overlapped with the key genes for cell trajectories identified in Farrell et al (Appendix 4). 
Most significant was the finding that a number of tailbud genes that Farrell et al associated 
with a mesodermal fate were downregulated in our analyses, while tailbud genes that 
Farrell et al associated with a neural fate were upregulated in our analyses (Appendix 4). 
Many of the genes Farrell et al  found to be key in underlying haematopoietic pronephron 
and cephalic mesoderm trajectories, two mesodermal fates, were significantly 
downregulated in our analyses (Appendix 4), further reinforcing the finding there is a skew 
from mesodermal fate to neural fate in rad21nz171 homozygote embryos.  
5.7 Conclusion 
The RNA sequencing analyses provided an abundance of data for further exploration. 2332 
genes were significantly downregulated in cohesin-deficient embryos and 1988 genes were 
significantly upregulated, highlighting just how crucial cohesin is in regulating gene 
expression. The in situ analyses on a number of the genes identified both in these and 
previous analyses highlighted in a visual manner how essential cohesin is for gene 
expression, and that deficiency in different cohesin subunits does not produce the same 
gene expression changes, likely due to the redundancy of some proteins compared to 
others. In our analyses the ability of the Stag proteins to compensate for one another was 
evident, yet when examining sema3ab expression stag1bnz205 homozygotes had an increase 
in expression in the posterior somites which indicates an affinity for stag1b-bound cohesin 
in regulating this gene. The similarity in expression patterns between rad21nz171 
heterozygote and wildtype siblings indicates that one functional copy of rad21 is sufficient 
for regulating gene expression. Rad21nz171 homozygote embryos, with no functional 
cohesin complexes formed, had significant changes in has2 and sema3ab gene expression 
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patterns. Pax2a expression patterns appeared consistent across all three genotypes from a 
rad21nz171 heterozygote in-cross, phenocopying the results from a stag1bnz205 in-cross. 
Wnt3a expression patterns in rad21nz171 embryos also phenocopied those seen in 
stag1bnz205 embryos, despite wnt3a expression in the tailbud of rad21nz171 homozygotes 
appearing diminished in comparison to their wildtype siblings.  
 
The pathway analyses provided numerous avenues for further investigation. Due to 
cohesins established role in cellular processes such as mitosis and DNA replication, it is not 
surprising these were identified were significantly downregulated.  Of interest is the 
apparent skew to neural ectoderm, as well as a potential role for cohesin in regulating 




6 THE UNCONSTRAINED CHROMATIN THEORY  
Cohesin is necessary for the regulation of many genes, but it is not clear how cohesin may 
be controlling their expression. We predict gene dysregulation to be a product of 
unconstrained chromatin in a cohesin-deficiency allowing ectopic signals to be interpreted. 
We have found that a major consequence of cohesin mutation is that cells skew away from 
mesoderm commitment and towards neuroectoderm in zebrafish tailbuds. Commitment to 
mesoderm is controlled by a Wnt signalling gradient in the tailbud (Martin et al., 2012). We 
hypothesised that disrupted Wnt signalling is partially responsible for cell fate changes in 
the tailbud, as indicated by a downregulation of Wnt3a (Figure 5-6). The zebrafish Wnt 
reporter line Tg(7xTCFXla.Siam:nlsmCherry)ia5 line expresses the mCherry fluorescent 
protein when Wnt target genes are activated. Stimulations with BIO-6 (a GSK-3 inhibitor) 
should allow more β-catenin to translocate to the nucleus, switching on mCherry. We 
hypothesise that in cohesin-deficient embryos, we will observe a difference in Wnt signal 
transduction. We predict that the levels of mCherry expression will differ in cohesin-
deficient embryos compared to wildtype. Comparing mCherry expression in cohesin-
deficient fish to mCherry expression in wildtype fish acts as a model for dysregulated Wnt 
signalling as a result of cohesin deficiency and is the first step in exploring the 
unconstrained chromatin theory. 
6.1 Toxicity testing of the WNT agonist 
The appropriate dosage for BIO (2’Z,3’E)-6-Bromoindirubin-3ʹ-oxime (BIO-6) stimulation 
was determined by conducting maximum tolerated dose studies. BIO-6 was tested at 6 
concentrations, 1, 2.5, 5, 7.5 and 10 μM, with doses higher than 5 μM being too toxic and 1 
μM being inefficacious. 2.5 μM was chosen as the effective treatment dosage, as embryos 




Figure 6-1 - Fish  experiments to examine the effect of cohesin-deficiency on Wnt signalling. For simplicity, 
genotypes denoted as ++ for homozygous functional, +- for heterozygous and -- for homozygous mutant. 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 fish referred to as mCherry in the diagram. Left: Rad21 morpholino 
injections into Tg(7xTCFXla.Siam:nlsmCherry)ia5 fish incross. Right: Outline of the necessary fish crosses 
required to generate homozygous mCherry-expressing embryos with comparable cohesin deficiencies.   
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6.2 Cohesin knockdown with rad21 morpholino 
A morpholino binds to endogenously produced mRNA, blocking its translation and 
intended function. Previous injections with a rad21 morpholino have been successful in 
knocking down rad21 function to explore the proteins normal role within a cell (Horsfield 
et al., 2007). Injections of rad21 morpholino into Tg(7xTCFXla.Siam:nlsmCherry)ia5 
embryos, and stimulation with BIO-6 resulted in embryo death, despite the previous 
success of the morpholino at these concentrations (Meier et al., 2018) and BIO-6 toxicity 
screening indicating that embryos can tolerate this dosage. Reducing the concentration of 
morpholino any further would not result in sufficient cohesin knockdown so that 
“knockdown” embryos could be compared to wildtype, and reducing the BIO-6 
concentration was not supported in the literature. Creating a stable line of transgenic, 
cohesin mutant fish was necessary to examine the effect of cohesin deficiency on WNT 
signalling.  
6.3 Creating a stable line of transgene carrying, cohesin deficient fish 
Figure 6-1 outlines the workflow necessary to create the Tg(7xTCFXla.Siam:nlsmCherry)ia5 
homozygote/Rad21nz171 heterozygote fish line required for further experiments. rad21nz171 
heterozygote fish were crossed to Tg(7xTCFXla.Siam:nlsmCherry)ia5 fish, and the offspring 
were grown out to adults, where they were TaqMan genotyped at the rad21nz171locus. Only 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 heterozygote/ rad21nz171  heterozygote fish were kept for 
further crosses (Green star in figure 6-1). 
 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 heterozygote/ rad21nz171 heterozygote fish were in-
crossed, and the embryos examined with confocal microscopy at 18 hpf (Appendix 4). Clear 
differences in the amount of fluorescence was evident between embryos, due to the 
offspring from this cross being either homozygous or heterozygous for 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 genotypes (See offspring genotypes in figure 6-1). It 
became apparent that stimulating fish from these in-crosses would not produce 
quantifiable changes in mCherry expression between Rad21 genotypes, as the embryos 
also had different degrees of mCherry expression based upon the number of copies of the 
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transgene inherited. To assay whether BIO-6 was toxic to mutant embryos, stimulations on 
a batch of the in-crosssed embryos was performed. The embryos survived, confirming that 
the 2.5 μM dosage is suitable.  
 
A back cross of Tg(7xTCFXla.Siam:nlsmCherry)ia5 heterozygote/ rad21nz171 heterozygote 
fish to the parent Tg(7xTCFXla.Siam:nlsmCherry)ia5 line is necessary, to produce offspring 
with two copies of the transgene. As fluorescence levels indicate how many copies of the 
transgene an embryo is carrying (Appendix 4), homozygous 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 embryos should be selected to be grown out to adult, 
where a fin clip can be taken and the fish genotyped for their rad21nz171status, with only 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 homozygote/ rad21nz171heterozygote fish kept for further 
experiments (Red star in figure 6-1). Tg(7xTCFXla.Siam:nlsmCherry)ia5 homozygote/ 
rad21nz171 heterozygote fish can be in-crossed to produce embryos that all have two copies 
of the transgene, but different functional rad21 dosages, making quantifiable mCherry 
expression changes  possible across cohesin-deficient genotypes. Due to time constraints, 
the backcross and subsequent genotyping has not been performed. 
6.4 Conclusion 
Knocking down rad21 expression in Tg(7xTCFXla.Siam:nlsmCherry)ia5 embryos and 
stimulating with BIO-6 was toxic to the embryos, yet stimulating 
Tg(7xTCFXla.Siam:nlsmCherry)ia5 heterozygote/ rad21nz171 heterozygote in-crossed 
embryos with 2.5 µm BIO-6 was not toxic to the embryos, indicating that the dosage is 
appropriate in mutant embryos, but not in combination with morpholino knockdown. 
Further fish crosses and genotyping must be performed so that stable lines of  
Tg(7xTCFXla.Siam:nlsmCherry)ia5 homozygote/ rad21nz171 heterozygote fish are available 
for in-crossing and subsequent BIO-6 stimulations to allow for the analysis of the Wnt 




7 DISCUSSION AND FUTURE DIRECTIONS 
7.1 Examining RAD21 functionality with a runx1 bioassay 
The zebrafish runx1 bioassay determined that the familial variant S449G-RAD21 is 
functional and the novel I152F-RAD21 variant is non-functional. It is not surprising that the 
familial variant was found to be functional, as the cohort of patients do not present with 
any cohesinopathy spectrum phenotypes, as would be expected if there was a reduction in 
functional cohesin in these patients (Horsfield et al., 2012). Though this bioassay confirmed 
that S449G-RAD21 is functional, it cannot determine if there are slight changes in the 
functionality of the cohesin complexes it forms. Knowing that S449G-RAD21 is functional 
shifts the focus from mitotic-failure driven cancer progression to gene expression-driven 
cancer and the way in which S449G-RAD21 functions in human cells to regulate gene 
expression must be explored. It may be that S449G-RAD21 can form cohesin complexes so 
that mitosis, DNA repair and gene expression can happen, but slight changes in cohesin 
binding or topological organisation of the chromatin results in cancer-driving gene 
expression changes. The novel variant I152F was produced at the opposite end of the 
RAD21 gene to S449G and introduced a large phenol group to the protein, in a bid to create 
protein folding changes or steric hindrance at the binding interface with SMC3. The 
bioassay determined that the novel variant is non-functional, and protein analysis 
determined that the variant site has potential to interfere with the binding to the SMC3 
ATPase head. It is possible that despite not being directly involved in binding the SMC3, 
that the changes in I152F-RAD21 still affect cohesin complex formation or interactions with 
any of the other cohesin-binding regulators.  It would be interesting to determine if this 
variant is identified in any future patients on the cohesinopathy spectrum. 
 
As there is no full RAD21 protein structure available; the sites where the variants are 
predicted to be located are only approximate. When a full structure becomes available, re-
examining the location of the variants within the 3D protein may shed further light onto 
the interactions that the I152F variant is involved in. The most significant outcome from 
these analyses was identifying how crucial functional annotation of variants is, especially in 
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a clinical setting. All of the protein prediction pipelines produced varying results about the 
pathogenicity of the two variants, both from one another and from our functional analyses. 
Though prediction algorithms are becoming increasingly more informative and accurate, 
they are not perfect, and when it comes to patient wellbeing, it is important to get them 
the most accurate information possible, through functional analysis.  
7.2 The role of cohesin in normal zebrafish embryogenesis 
The high-throughput RNA sequencing and analysis identified over four thousand 
significantly dysregulated genes in cohesin-deficiency. We examined just four of these via 
in situ hybridisation. Wnt3a was found to be significantly down-regulated in rad21nz171 
homozygote tailbuds compared to wildtype and as this gene is one of the master regulators 
of axial extension, we wanted to examine its expression pattern in wildtype and rad21nz171 
tailbuds. We chose the other three genes because they overlap with genes previously 
identified as dysregulated in cohesin-deficiency at an earlier time point in embryogenesis 
(Meier et al., 2018). Assaying the expression patterns of the identified genes is necessary to 
build a bigger picture of cohesin-deficient embryo development. We hoped to visualise if 
any of the four genes exhibited marked differences in expression patterns on embryos 
produced from the in-cross of adult heterozygote rad21nz171 and stag1bnz205 zebrafish. In 
this manner, any dysregulation could be examined across wildtype, heterozygous and 
homozygous mutant siblings, as well as between different cohesin-subunit genotypes.  
7.2.1 Comparing gene expression patterns across cohesin subunits 
As there are four Stag orthologues in zebrafish, expression patterns of the four genes were 
expected to be consistent across the different stag1bnz205 genotypes, due to any of the 
other stag orthologues compensating for a loss of stag1b. Compensation was apparent for 
regulating all genes except for sema3ab, in which the stag1bnz205 heterozygotes had a 
decrease in craniofacial expression, and homozygotes had distinctly different expression in 
the somites, indicating a favourability of stag1b-associated cohesin in regulating sema3ab 
expression. As there was not a total reduction in sema3ab expression, it is clear that 
orthologous stag proteins are sufficient to support regulation, also supported by the fact 
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that a total stag1b knockout is survivable (Muto & Schilling, 2017). As stag1bnz205 fish are 
homozygous viable, serious posterior patterning defects were not expected.   
 
Unlike a homozygous stag1b loss, a homozygous rad21 loss is lethal, as there are no 
compensatory proteins that can perform its role, and thus a homozygous rad21 loss 
produces a total cohesin knockout (Sonoda et al., 2001). One of the key observations from 
the expression analyses was how indistinguishable rad21nz171 heterozygotes are from their 
wildtype siblings, despite having a 50% reduction in functional cohesin. This indicates that 
one functional copy of the rad21 allele is sufficient for normal expression of most of the 
genes during development, and is supported by the fact that mutations in rad21 tend to 
produce mild cohesinopathy phenotypes (Minor et al., 2014), as the functional rad21 allele 
can compensate for the non-functional so that development is relatively unaffected.   
 
We hoped to examine if a reduction in different cohesin subunits produced similar gene 
expression patterns. Similarities in spatiotemporal gene expression between stag1bnz205 
and rad21nz171 heterozygotes and their wildtype siblings was clear and is evidently due to 
the fact that a single copy of rad21 is sufficient for expression, and likewise a single copy of 
stag1b, in combination with numerous orthologous proteins, allows normal gene 
expression. Pax2a gene expression was similar for rad21nz171 and stag1bnz205 homozygous 
embryos.  
 
Stag orthologues were sufficient to regulate wnt3a and has2 gene expression in the 
absence of stag1b, producing homozygous mutants with phenotypes indistinguishable 
from their siblings with functional stag1b. Rad21nz171 homozygous embryos have no 
orthologous protein redundancy pathways available, and wnt3a and has2 gene expression 
patterns were consequently affected. Interestingly, stag1bnz205 homozygous embryos did 
not have similar sema3ab expression patterns to their siblings with functional stag1b, and 
the change in expression pattern did not phenocopy the total loss of sema3ab expression 
observed in rad21nz171 homozygous embryos, indicating that while a total stag1b loss 
affects gene expression, it is not to the same degree that a rad21 loss does. These findings 
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are consistent with the fact that a total rad21 knockout is lethal, while a stag1b knockout is 
survivable.  
 
It is important to note that though differences in expression patterns were not strikingly 
obvious at this time point for all four genes, it does not mean that at other points in 
embryogenesis these genes are not significantly visibly different in cohesin-deficient 
embryos compared to wildtype. As all four of these genes were identified as significantly 
dysregulated in cohesin-deficient embryos, there may be very small differences in gene 
expression patterns across these genotypes that could not be quantified, and that in reality 
may underlie some of the significant clinical presentations of the cohesinopathies.  
7.2.2 Unsurprising dysregulated pathways in cohesin knockout 
As cohesin is so fundamental in key cellular processes, it is no surprise to see a large 
number of these significantly downregulated in the pathway analyses. DNA replication, cell 
cycle, double strand break repair and mitotic control pathways were all significantly down-
regulated, consistent with previous research that establishes cohesin as a regulator of 
these processes. Downstream of these key biological processes, organ development, 
embryo patterning and general growth pathways are consequently also significantly 
downregulated. 
7.2.3 A role for cohesin in regulating gene expression through translation 
Interestingly, a number of the most down-regulated processes were those relating to 
ribosome biogenesis and ribonucleoprotein complex biogenesis, yet there is limited 
research supporting a role for cohesin in regulating gene expression through enabling RNA 
translation and protein production. Bose et al show that in yeast and human cells, Roberts 
Syndrome associated mutations, in SMC and ESCO-1, a cohesin loading factor, less 
ribosomal RNA is produced and the effect of this is expected to constrain protein synthesis, 
thus essential proteins are not translated, and developmental defects arise (Bose et al., 
2012). Our findings support a reduction in essential protein production machinery when 
cohesin is lost, which brings a whole new level of cohesin regulation on gene expression to 
the forefront. Not only can cohesin regulate gene expression at the transcriptional level 
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through chromatin organisation, it may be essential in helping the translation of these 
genes from mRNA to protein.  
 
Ribosomes are so essential they are synthesised within a cell at a rate of thousands per 
minute (Fatica & Tollervey, 2002). Defects in ribosome biogenesis or ribonucleoprotein 
complex biogenesis would therefore be expected to be lethal, as without creating 
thousands of these structures, essential proteins cannot be formed effectively. A number 
of human diseases related to ribosome-biogenesis are surprisingly survivable, resulting in 
tissue-specific pathologies, a number of which have clinical presentations that overlap with 
the cohesinopathy spectrum. Mutations in TCOF, a ribosome biogenesis protein, results in 
craniofacial abnormalities similar to CdLS, with large eyes and small chins (Freed et al., 
2010). Mutations in RMRP, a small nucleolar ribonucleoprotein, phenocopy CdLS also, with 
short stature and mental retardation (Freed et al., 2010). It is possible that some of the 
phenotypes observed in the cohesinopathy spectrum are due to issues in cohesins ability to 
assist in ribosome biogenesis.   
7.2.4 Gene dysregulation is not equal across zebrafish chromosomes 
An unexpected finding was that gene dysregulation was not equal across all zebrafish 
chromosomes. Chromosome 12 and 16 had significantly increased levels of dysregulation 
compared to all other chromosomes. Interestingly, rad21 is located on zebrafish 
chromosome 16. It is possible that in the absence of functional rad21, cell transcription 
machinery preferentially transcribed from chromosome 16, in a bid to produce rad21 
proteins, and in doing so increased the expression of surrounding genes.  
7.2.5 Stem cell fates skewed towards neural ectoderm 
Perhaps the most striking finding was that bipotent stem cells in a cohesin-deficient tailbud 
appear to skew cell fate decisions towards neural ectoderm, as there was a significant 
increase in the expression of genes related to neural processes and neural pathway 
upregulation and a significant decrease in mesodermal processes and mesodermal 








Figure 7-1 - Tailbud tissues, and proposed misspecification models. Schematics of tailbud structures within 
the zebrafish tailbud. The tailbud is oriented A-P. Blue – Neuromesodermal progenitor population. Yellow – 
Mesodermal progenitor population. Purple – Neural ectoderm. Green – vascular endothelium. Teal – 
Presomitic mesoderm. Stripes in the presomitic mesoderm represent formed somites. Top tailbud schematic 
depicts the normal distribution of tissues in a developing tailbud and shows expression levels of key genes in 
the tissues. Middle tailbud schematic depicts potential expansion of neural-fated cells and two proposed ways 
in which cohesin-deficient embryos may gain this. The top red arrow represents a spatial expansion of neural 
progenitors, while the bottom red arrow represents NMPs specifying into neural cells rather than mesodermal 
progenitors. The bottom panel shows wnt3a expression in wildtype (left) and rad21nz171  homozygote (right) 
tailbuds at 18hpf. Images originally from figure 5-6 but rotated to allow comparison to tissue distribution 





The first decision that a neuro-mesodermal progenitor stem cell (NMP) at the very 
posterior of the tailbud must make is between a neural or mesodermal fate. The 
schematics in figure 7-1 depict an elongating tailbud, and shows the distribution of these 
tissues throughout the structure. (Gouti et al., 2014). Wnt3a and wnt8 signalling drives 
NMPs towards a mesodermal fate (yellow in figure 7-1), and a reduction in Wnt signaling 
drives a neural fate, as sox2 levels increase (purple in figure 7-1) (Gouti et al., 2014). In RNA 
sequencing and subsequent in situ hybridisation analyses, we showed that wnt3a 
expression is downregulated in rad21nz171 tailbuds compared to wildtype, thus an increased 
number of progenitor cells are likely to specify into neural rather than mesodermal fates. 
 
The NMPs arrest in G2 phase, just before mitosis, ahead of fate commitment (Mastromina 
et al., 2017). In rad21nz171 homozygotes, NMPs take longer to progress through mitosis as 
Rad21-deficient embryos cannot perform the cell cycle efficiently (Appendix 4). It may be 
that holding NMPs in G2 has some effect on cell fate decisions which contributes to the 
observed skew to neural ectoderm, though this remains to be explored.  
 
Though wnt3a levels are significantly downregulated in rad21nz171 homozygotes, some 
NMPs will still have sufficient wnt8 expression levels to specify into mesodermal 
progenitors, supported by the fact that these rad21nz171 homozygote embryos are 
phenotypically indistinguishable from their wildtype siblings at this stage, where there are 
numerous mesodermal structures such as the somites present. Up until this time point, the 
genotypically homozygous mutant embryo has not been a total cohesin knockout. 
Maternal constructs, identified in trace amounts in genotypically mutant embryos, could 
also be assisting in the production of mesodermal progenitors from NMPs. The exciting 
aspect of assaying embryo expression profiles at this stage in development is that this is 
the cusp of no residual maternal transcripts and therefore the effect of a total loss of 
cohesin on expression at this developmental stage can be observed.  
 
There are two ways in which neural processes are appearing upregulated at the expense of 
mesodermal. Either NMPs are undergoing a cell fate decision change in the absence of 
sufficient Wnt signalling and becoming neural, or neural progenitors are produced as 
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normal, due to up-regulated sox2 signalling, and because there are fewer mesodermal 
progenitors being produced, there is an expansion of neural progenitors into space that 
would normally be occupied by mesodermal progenitors (Figure 7-1 - middle).  
7.2.6 Wnt signalling is required throughout axial elongation 
Wnt signalling drives multiple decisions in axial elongation. FGF and Wnt normally 
upregulate tbx6/16 in mesodermal progenitor cells (Yellow in figure 7-1), which suppresses 
sox2, and associated neural fate (Goto et al., 2017). A number of FGF genes were 
upregulated in the cohesin knockouts, and the Tbx genes remained unaffected. There is 
potential that the upregulation of FGF genes compensates for the downregulation of Wnt, 
maintaining tbx6/16 expression, and thus maintaining a mesodermal progenitor state by 
suppressing sox2.  
 
Those NMPs that do successfully differentiate into mesodermal progenitors require Wnt 
signalling for a second cell fate decision, between paraxial mesoderm and vascular 
endothelium (Teal and green respectively in figure 7-1) (Goto et al., 2017). High Wnt 
expression drives a number of genes required for transitioning into paraxial mesoderm, 
including msgn1 – the master regulator of paraxial mesodermal fate (Yabe & Takada, 
2012). Despite the upregulation of FGF, which is thought to supplement WNTs activation of 
this gene, msgn1 is severely down-regulated, in fact it is the most significantly down-
regulated gene identified in the analyses, likely because wnt3a cannot activate it. It is likely 
that the paraxial mesoderm and related structures will not form correctly in cohesin-
deficient embryo from this time point, as there is now no maternal deposited RNA to 
supplement development. A low Wnt gradient in mesodermal progenitors allows cells to 
differentiate into vascular endothelium (Dunty et al., 2008). In our analyses there is no 
upregulation of vascular processes, rather a down-regulation. As it appears there has been 
a significant downregulation of mesodermal fates as a whole, a specification of the 
dwindling mesodermal progenitors into vascular endothelium will not appear as a 




Numerous other genes that relate to formation of mesodermal structures are down 
regulated, eve1 and foxa1, which work to regulate mesodermal differentiation, and her1 
and her6 , which assists in somite formation (Henry et al., 2002). Due to the initial 
allocation of NMPs into neural and mesodermal fates being skewed towards neural 
ectoderm, it is no surprise that many of the downstream pathways and structures in these 
cell lineages are also dysregulated.  
7.2.7 What is underlying the gene expression changes 
I theorise that the shift toward neural processes is due to cohesin dysregulation of wnt3a, 
or genes that interact with wnt3a, as opposed to cohesin up-regulation of sox2, and the 
associated neural fate. If wnt3a levels are being down-regulated as a result of cohesin loss, 
either model of neural cell expansion (Figure 7-1 - middle) results in the overall increase (or 
apparent up-regulation) in sox2 expression observed in these analyses. The wnt3a 
expression pattern in wildtype and cohesin-deficient embryos, when compared to a 
schematic outlining the normal tissue distribution in the tailbud (figure 7-1) supports the 
notion that there is insufficient wnt3a present in both NMPs and mesodermal progenitors 
to commit cells to the correct mesodermal fates in cohesin-deficient embryos, as there is 





      
  
Figure 7-2 - Proposed models of unconstrained chromatin affecting gene expression. Left panel – Cohesin-
deficiency allowing a repressor which was once contained within a cohesin insulated domain to act on 
multiple genes. Right panel – Cohesin deficiency reducing contacts in the chromatin. Without cohesin 
regulation the pink enhancer cannot activate expression of the green gene.  
One theory as to how cohesin-deficiency affects genes in development is that cohesin-
deficient cells are open to ectopic signalling, through unconstrained chromatin, allowing 
signals which cannot normally affect expression having an effect. Repressors which are 
normally sequestered away from wnt3a by cohesin organisation of chromatin may now be 
able to act on wnt3a directly, repressing its expression (Figure 7-2 – left panel). Any 
number of the plethora of gene products that regulate Wnt signalling may also be open to 
ectopic signals. For example, BMP upregulates Wnt signalling, by repressing Wnt inhibitors 
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in the very posterior of the tailbud (Row & Kimelman, 2009). We observed a down 
regulation of multiple BMP genes, which would allow Wnt inhibitor levels to increase, 
reducing wnt3a signal and all downstream pathways.  
 
Another theory is that a lack of cohesin may affect gene expression more directly, through 
insufficient organisation of local chromatin organisation. The right panel in figure 7-2 
depicts a green gene which is expressed when cohesin organisation brings a purple 
enhancer within its proximity. In a cohesin deficiency, this regulation may not occur, and 
genes are therefore not expressed. Wnt3a expression levels may have dropped in 
rad21nz171 homozygote tailbuds due to a lack of cohesin regulating its expression by 
enhancer interactions.  
 
We aimed to test the unconstrained chromatin theory by comparing expression intensity of 
the mCherry reporter, and by proxy, Wnt target gene expression in a developing embryo, in 
transgenic lines of cohesin-deficient vs cohesin-present fish. Unfortunately, this work was 
not completed in the scope of this masters.  
7.2.8 How do our findings relate to the developmental defects seen in humans? 
The specific genes that are dysregulated in cohesin-deficient zebrafish embryos do not 
necessarily directly relate to human cohesinopathy traits. Though both species are 
vertebrates, zebrafish, which are amniotes, have slightly differing axial extension 
programmes to mammals, and thus different pathways can be affected by cohesin 
reduction. Though it is exciting to see which genes are dysregulated in cohesin-deficient 
zebrafish tailbuds, it does not allow verification of how cohesin regulates these genes. 
Determining how cohesin regulates the expression of genes to allow these changes in 
pathways is the next step in deciphering the cohesinopathies.  
7.3 Future directions  
Many exciting leads came out of these analyses, and examination of proposed ideas could 
solidify the theories. The ideal next step in examining dysregulated gene expression and 
cell fate skewing in cohesin-deficient embryos would be to perform double fluorescent in 
68 
 
situ hybridisation of sox2 and wnt3a genes in cohesin-deficient compared to wildtype 
tailbuds. Examining expression of these two genes with Nikon C2 confocal microscopy 
would allow much higher magnification of the tailbud cells and may allow visualisation of 
the proposed expansion of neural ectoderm. 
 
Continuing with analysis of the impact of signalling pathways on chromatin is also crucial in 
elucidating cohesins role in developmental gene expression. To continue this, outcrosses 
and subsequent BIO-6 stimulations should be performed as outlined in figure 6-1. 
7.4 Conclusions 
This Masters research first aimed to uncover the functionality of a familial RAD21 variant 
that may be causative of myeloid dysplasia observed in a cohort of patients. It was 
determined via a runx1 in situ hybridisation assay that the variant does produce a 
functional RAD21 protein, and protein mapping of the variant site within the 3D RAD21 
molecule predicts that the variant does not lie within RAD21 interacting domains. Any 
effect this variant has on RAD21 functionality in these patients is therefore predicted to be 
due to changes in variant-cohesin interactions with the genome, which was not further 
explored in the scope of this Masters. 
 
This research also aimed to explore the effect that cohesin has on regulating gene 
expression in a bipotential progenitor cell population in the developing embryo. Through a 
high-throughput RNA-sequencing experiment on the tailbuds of cohesin-deficient zebrafish 
embryos compared to their wildtype siblings, it was determined that a loss of cohesin 
resulted in this bipotent stem cell population skewing towards neural ectoderm, at the 
expense of mesodermal progenitors. This skewing is theorised to be due to a lack of 
cohesin regulation of wnt3a – either directly, or through its numerous regulators. A role for 
cohesin in regulating gene expression at the translational level was also uncovered, as in 





The abundance of data generated from the RNA-sequencing analysis opens many new 
doors for exploration into cohesins role in regulating gene expression throughout 
development.       
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APPENDIX 1 – CHEMICALS AND SOLUTIONS  
All solutions were made using sterile milli-Q water unless otherwise stated. The pH 
adjustments were made using 1 M HCl or NaOH.  
 
Luria-Broth (LB) Medium  - 4 g Tryptone, 2 g Yeast extract, 4 g Sodium Chloride, make up to 
400mL with milli Q water. Sterilise by autoclaving.  
 
LB agar  - 4 g Tryptone, 2 g Yeast extract, 4 g Sodium Chloride, 6g bacterial agar, make up to 
400mL with milli Q water. Sterilise by autoclaving.  
 
Ethanol - Absolute ethanol dissolved in ddH2O to final concentrations of 70% and 80% 
 
Glycerol - Glycerol dissolved in UP water to final concentrations of 30% and 80% 
 
Agarose Gels - The desired percentage produced by dissolving agarose powder in 1 x TAE. 
Per 60 mL gel, 3.6uL of ethidium bromide added.  
 
50 x E3  - 14.6g NaCl, 0.63g KCl, 2.43gCaCl2H2O, 4.07g MgSO47H2O, make up to 1 litre with 
MilliQ water, and pH to 7.2. Sterilise by autoclaving. E3 used at a 1x concentration.  
 
7%DMSO 




List of solutions used in in situ hybridisation.  
All solutions were autoclaved. 
Solution name Component Amount 
10 x Phosphate buffered 
saline (PBS) (pH 7.4) 
 
Potassium chloride (KCl) 2.0g 
Potassium phosphate (KH2PO4)   2.0g 
Sodium phosphate (NA2PO4-2H2O) 14.4g 
Sodium chloride (NaCl) 80.0g 
MilliQ 1L 
1x PBS 10X PBS 100mL 
MilliQ 900mL 
1 x Phosphate buffered saline 
with Tween (PBST) 
1 X PBS 1L 
Tween 20 200mL 
20x Saline sodium citrate 
(SSC) buffer (pH 7) 
 Sodium chloride (NaCl) 175.3g 




acid (EDTA)  
EDTA 18.6g 
sodium hydroxide (NaOH) 2.0g 
MilliQ 100mL 
Hybridisation Buffer (HB+) pH 
6.0 
formamide 25mL 
20x SSC 12.5mL 
Heparin(5mg/mL) 500mL 
0.5M EDTA 500mL 
tRNA from wheat germ type V (50ug/mL) 250uL 
20% Tween 20 250uL 
1M Citric acid (C6H8O7) 460uL 
MilliQ 11.5mL 
Hybridisation Buffer (HB-) pH 
6.0 
formamide 25mL 
20x SSC 12.5mL 
0.5M EDTA 500mL 
20% Tween 20 250uL 
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1M Citric acid (C6H8O7) 460uL 
MilliQ 11.5mL 
10x Maleic acid buffer (MAB) Maleic acid (C4H4O4)  116g 
sodium chloride (NaCl) 87g 
sodium hydroxide (NaOH) 40g 
MilliQ 1L 
1 x MAB 10x MAB 100mL 
MilliQ 900mL 
2% Roche blocking buffer Roche blocking agent (2% weight/volume) 
dissolved at 60 degrees 
1g 
1x MAB 50mL 
Staining solution 1M Tris pH 9.5 5mL 
2M magnesium chloride (MgCl2) 1.25mL 
5M sodium chloride (NaCl) 1mL 






APPENDIX 2 – PLASMID MAPS 
Runx1 
 
Depiction of the pBS-KS runx1 plasmid. HINDIII and ECOR1 sites identified. SP6/T3 and T7 primer directions 
also identified. 
WT-rad21 and rad21nz171 
 
Depiction of the PCS2+ rad21 plasmids. Not1, HINDIII and ECOR1 sites identified. SP6 and T7 primer directions 




APPENDIX 3 - PRIMER LIST 
Details of the primers used in this research are listed below 
Primer Direction Sequence 
mCherry Forward CCCCGTAATGCAGAAGAAGA 
mCherry Reverse TTGGTCACCTTCAGCTTGG 
































APPENDIX 4 – SUPPLEMENTARY  
Control and variant rad21 mRNA visualisation 
 
 
Detecting presence of mRNA on 2% agarose gel run for 2hours at 100V. Lane 1: Invitrogen 1kb ladder, 2: WT-
rad21 mRNA, 3: rad21nz171 mRNA, 4: I152F-rad21 mRNA, 5: S449G-rad21 mRNA. 
STRUM 3D protein prediction 
  
STRUM outputs depicting predicted protein structure for I152F-Rad21 (A) and S449G-Rad21 (B). The variant 




















Further PCA plots, demonstrating similarity between replicates. The four wildtype replicates are depicted in 




Gene dysregulation across zebrafish chromosomes  
 
 
Table listing all zebrafish chromosomes and the expected and observed amounts of gene dysregulation in the 









Table adapted from Farrell et al supplementary. These gene lists were created to demonstrate the key genes 
underlying distinct cell trajectories. Red highlighted genes were downregulated in our RNAseq analyses. Blue 
highlighted genes were upregulated in our RNAseq analyses 
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Embryos imaged after stimulation with BIO-6 for 12 hours. Top. Embryos after stimulation with 5 uM BIO-6. 
The tailbuds of the embryos are stumpy in comparison to those treated with 2.5 uM BIO-6, and the embryos 
are dying. Bottom - Embryos after stimulation with 2.5 uM BIO-6. Development of the embryo appears 








MCherry fluorescence in embryos from a Tg(7xTCFXla.Siam:nlsmCherry)ia5 heterozygote/ rad21nz171 
heterozygote fish in-cross at 18 hpf. There is clear distinction between offspring embryos carrying one copy of 
the transgene (top) and two copies of the transgene (bottom) based upon the degree of fluorescence.  
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Rad21 mutants in mitotic delay 
 
 
Image adapted  from Horsfield et al 2007. Phosphohistine H3 labelling of M phase shows more cells with 
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